{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:35:11Z","timestamp":1792798511399,"version":"4.5.0"},"reference-count":370,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"DOI":"10.1007\/s10048-024-00779-3","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T02:02:39Z","timestamp":1726192959000},"page":"307-336","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The role of gut-derived short-chain fatty acids in Parkinson's disease"],"prefix":"10.1007","volume":"25","author":[{"given":"Mohamed J.","family":"Saadh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anfal Nabeel","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Ahmed","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renuka Jyothi.","family":"S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan Khalid","family":"Dabis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. V. Siva","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imad Jassim","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Adnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameer Hassan","family":"Idan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,13]]},"reference":[{"issue":"1","key":"779_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W et al (2017) Parkinson disease. Nat Rev Dis Primers 3(1):1\u201321","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"779_CR2","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.3390\/nu15122775","volume":"15","author":"L Ortega Moreno","year":"2023","unstructured":"Ortega Moreno L et al (2023) New pieces for an old puzzle: Approaching Parkinson\u2019s disease from translatable animal models, gut microbiota modulation, and lipidomics. Nutrients 15(12):2775","journal-title":"Nutrients"},{"key":"779_CR3","doi-asserted-by":"crossref","unstructured":"Zhu B, Yin D, Zhao H, Zhang L (2022) The immunology of parkinson\u2019s disease. in seminars in immunopathology, vol 44, No. 5. Springer, Heidelberg, pp 659\u2013672","DOI":"10.1007\/s00281-022-00947-3"},{"issue":"8","key":"779_CR4","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.14336\/AD.2021.0418","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y et al (2021) Intestinal inflammation and Parkinson\u2019s disease. Aging Dis 12(8):2052","journal-title":"Aging Dis"},{"issue":"1","key":"779_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","volume":"36","author":"DK Simon","year":"2020","unstructured":"Simon DK, Tanner CM, Brundin P (2020) Parkinson disease epidemiology, pathology, genetics, and pathophysiology. Clin Geriatr Med 36(1):1\u201312","journal-title":"Clin Geriatr Med"},{"issue":"6285","key":"779_CR6","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1126\/science.aad3503","volume":"352","author":"G Falony","year":"2016","unstructured":"Falony G et al (2016) Population-level analysis of gut microbiome variation. Science 352(6285):560\u2013564","journal-title":"Science"},{"issue":"1","key":"779_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13073-017-0428-y","volume":"9","author":"JR Bedarf","year":"2017","unstructured":"Bedarf JR et al (2017) Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-na\u00efve Parkinson\u2019s disease patients. Genome Med 9(1):39","journal-title":"Genome Med"},{"issue":"10","key":"779_CR8","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/nutrit\/nuw023","volume":"74","author":"F Pistollato","year":"2016","unstructured":"Pistollato F et al (2016) Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease. Nutr Rev 74(10):624\u2013634","journal-title":"Nutr Rev"},{"issue":"4","key":"779_CR9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/joim.12508","volume":"280","author":"T Arora","year":"2016","unstructured":"Arora T, B\u00e4ckhed F (2016) The gut microbiota and metabolic disease: current understanding and future perspectives. J Intern Med 280(4):339\u2013349","journal-title":"J Intern Med"},{"issue":"9","key":"779_CR10","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3109\/00207454.2015.1096271","volume":"126","author":"X Fang","year":"2016","unstructured":"Fang X (2016) Potential role of gut microbiota and tissue barriers in Parkinson\u2019s disease and amyotrophic lateral sclerosis. Int J Neurosci 126(9):771\u2013776","journal-title":"Int J Neurosci"},{"issue":"8","key":"779_CR11","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/mds.25736","volume":"29","author":"LP Kelly","year":"2014","unstructured":"Kelly LP et al (2014) Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson\u2019s disease. Mov Disord 29(8):999\u20131009","journal-title":"Mov Disord"},{"issue":"12","key":"779_CR12","doi-asserted-by":"publisher","first-page":"e28032","DOI":"10.1371\/journal.pone.0028032","volume":"6","author":"CB Forsyth","year":"2011","unstructured":"Forsyth CB et al (2011) Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease. PLoS ONE 6(12):e28032","journal-title":"PLoS ONE"},{"issue":"6","key":"779_CR13","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson TR et al (2016) Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson\u2019s Disease. Cell 167(6):1469-1480.e12","journal-title":"Cell"},{"key":"779_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","volume":"32","author":"MM Unger","year":"2016","unstructured":"Unger MM et al (2016) Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls. Parkinsonism Relat Disord 32:66\u201372","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"779_CR15","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mds.26942","volume":"32","author":"EM Hill-Burns","year":"2017","unstructured":"Hill-Burns EM et al (2017) Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome. Mov Disord 32(5):739\u2013749","journal-title":"Mov Disord"},{"issue":"s2","key":"779_CR16","doi-asserted-by":"publisher","first-page":"S297","DOI":"10.3233\/JPD-191711","volume":"9","author":"JM Boertien","year":"2019","unstructured":"Boertien JM et al (2019) Increasing comparability and utility of gut microbiome studies in Parkinson\u2019s disease: a systematic review. J Parkinsons Dis 9(s2):S297\u2013S312","journal-title":"J Parkinsons Dis"},{"issue":"2","key":"779_CR17","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1113\/JP273106","volume":"595","author":"TG Dinan","year":"2017","unstructured":"Dinan TG, Cryan JF (2017) Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration. J Physiol 595(2):489\u2013503","journal-title":"J Physiol"},{"issue":"1","key":"779_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41531-016-0002-0","volume":"3","author":"MC Houser","year":"2017","unstructured":"Houser MC, Tansey MG (2017) The gut-brain axis: is intestinal inflammation a silent driver of Parkinson\u2019s disease pathogenesis? NPJ Park Dis 3(1):3","journal-title":"NPJ Park Dis"},{"issue":"10","key":"779_CR19","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1136\/gut.28.10.1221","volume":"28","author":"JH Cummings","year":"1987","unstructured":"Cummings JH et al (1987) Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28(10):1221\u20131227","journal-title":"Gut"},{"issue":"7","key":"779_CR20","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.cell.2016.05.018","volume":"165","author":"GE Kaiko","year":"2016","unstructured":"Kaiko GE et al (2016) The colonic crypt protects stem cells from microbiota-derived metabolites. Cell 165(7):1708\u20131720","journal-title":"Cell"},{"issue":"2","key":"779_CR21","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S0016-5085(82)80339-9","volume":"83","author":"W Roediger","year":"1982","unstructured":"Roediger W (1982) Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 83(2):424\u2013429","journal-title":"Gastroenterology"},{"issue":"5","key":"779_CR22","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.chom.2015.03.005","volume":"17","author":"CJ Kelly","year":"2015","unstructured":"Kelly CJ et al (2015) Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe 17(5):662\u2013671","journal-title":"Cell Host Microbe"},{"issue":"4","key":"779_CR23","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/S0016-5085(00)70142-9","volume":"118","author":"MS Inan","year":"2000","unstructured":"Inan MS et al (2000) The luminal short-chain fatty acid butyrate modulates NF-\u03baB activity in a human colonic epithelial cell line. Gastroenterology 118(4):724\u2013734","journal-title":"Gastroenterology"},{"issue":"8","key":"779_CR24","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","volume":"16","author":"B Dalile","year":"2019","unstructured":"Dalile B et al (2019) The role of short-chain fatty acids in microbiota\u2013gut\u2013brain communication. Nat Rev Gastroenterol Hepatol 16(8):461\u2013478","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"779_CR25","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/mds.28052","volume":"35","author":"MS Cirstea","year":"2020","unstructured":"Cirstea MS et al (2020) Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson\u2019s Disease. Mov Disord 35(7):1208\u20131217","journal-title":"Mov Disord"},{"key":"779_CR26","doi-asserted-by":"publisher","first-page":"e26377","DOI":"10.1016\/j.heliyon.2024.e26377","volume":"10","author":"Z Lan","year":"2024","unstructured":"Lan Z et al (2024) The role of short-chain fatty acids in central nervous system diseases: A bibliometric and visualized analysis with future directions. Heliyon 10:e26377","journal-title":"Heliyon"},{"issue":"6","key":"779_CR27","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.neuron.2019.02.008","volume":"101","author":"C F\u00fclling","year":"2019","unstructured":"F\u00fclling C, Dinan TG, Cryan JF (2019) Gut Microbe to Brain Signaling: What Happens in Vagus\u2026. Neuron 101(6):998\u20131002","journal-title":"Neuron"},{"key":"779_CR28","doi-asserted-by":"publisher","first-page":"1225875","DOI":"10.3389\/fnins.2023.1225875","volume":"17","author":"H Ullah","year":"2023","unstructured":"Ullah H et al (2023) The gut microbiota-brain axis in neurological disorder. Front Neurosci 17:1225875","journal-title":"Front Neurosci"},{"issue":"1","key":"779_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41392-024-01743-1","volume":"9","author":"JS Loh","year":"2024","unstructured":"Loh JS et al (2024) Microbiota\u2013gut\u2013brain axis and its therapeutic applications in neurodegenerative diseases. Sig Transduct Target Ther 9(1):37","journal-title":"Sig Transduct Target Ther"},{"issue":"39","key":"779_CR30","doi-asserted-by":"publisher","first-page":"6715","DOI":"10.3748\/wjg.v27.i39.6715","volume":"27","author":"S Baldi","year":"2021","unstructured":"Baldi S et al (2021) Microbiota shaping\u2014The effects of probiotics, prebiotics, and fecal microbiota transplant on cognitive functions: A systematic review. World J Gastroenterol 27(39):6715","journal-title":"World J Gastroenterol"},{"issue":"5","key":"779_CR31","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1128\/aem.62.5.1589-1592.1996","volume":"62","author":"TL Miller","year":"1996","unstructured":"Miller TL, Wolin MJ (1996) Pathways of acetate, propionate, and butyrate formation by the human fecal microbial flora. Appl Environ Microbiol 62(5):1589\u20131592","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"779_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1574-6968.2009.01514.x","volume":"294","author":"P Louis","year":"2009","unstructured":"Louis P, Flint HJ (2009) Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 294(1):1\u20138","journal-title":"FEMS Microbiol Lett"},{"issue":"6","key":"779_CR33","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.1038\/nutd.2014.23","volume":"4","author":"J Fernandes","year":"2014","unstructured":"Fernandes J et al (2014) Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans. Nutr Diabetes 4(6):e121\u2013e121","journal-title":"Nutr Diabetes"},{"issue":"1","key":"779_CR34","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41467-019-08711-2","volume":"10","author":"M Luu","year":"2019","unstructured":"Luu M et al (2019) The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes. Nat Commun 10(1):760","journal-title":"Nat Commun"},{"issue":"1","key":"779_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/1462-2920.13589","volume":"19","author":"P Louis","year":"2017","unstructured":"Louis P, Flint HJ (2017) Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol 19(1):29\u201341","journal-title":"Environ Microbiol"},{"issue":"5","key":"779_CR36","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1006\/anae.1997.0121","volume":"3","author":"EA Smith","year":"1997","unstructured":"Smith EA, Macfarlane G (1997) Dissimilatory amino acid metabolism in human colonic bacteria. Anaerobe 3(5):327\u2013337","journal-title":"Anaerobe"},{"issue":"1","key":"779_CR37","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/mnfr.201100542","volume":"56","author":"K Windey","year":"2012","unstructured":"Windey K, De Preter V, Verbeke K (2012) Relevance of protein fermentation to gut health. Mol Nutr Food Res 56(1):184\u2013196","journal-title":"Mol Nutr Food Res"},{"issue":"10","key":"779_CR38","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.1128\/AEM.68.10.5186-5190.2002","volume":"68","author":"SH Duncan","year":"2002","unstructured":"Duncan SH et al (2002) Acetate utilization and butyryl coenzyme A (CoA): acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Appl Environ Microbiol 68(10):5186\u20135190","journal-title":"Appl Environ Microbiol"},{"issue":"6","key":"779_CR39","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1079\/BJN20041150","volume":"91","author":"SH Duncan","year":"2004","unstructured":"Duncan SH et al (2004) Contribution of acetate to butyrate formation by human faecal bacteria. Br J Nutr 91(6):915\u2013923","journal-title":"Br J Nutr"},{"issue":"10","key":"779_CR40","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2174\/13816128113199990462","volume":"20","author":"N Vijay","year":"2014","unstructured":"Vijay N, Morris ME (2014) Role of monocarboxylate transporters in drug delivery to the brain. Curr Pharm Des 20(10):1487\u20131498","journal-title":"Curr Pharm Des"},{"issue":"6","key":"779_CR41","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1194\/jlr.R067629","volume":"57","author":"P Sch\u00f6nfeld","year":"2016","unstructured":"Sch\u00f6nfeld P, Wojtczak L (2016) Short-and medium-chain fatty acids in energy metabolism: the cellular perspective. J Lipid Res 57(6):943\u2013954","journal-title":"J Lipid Res"},{"issue":"4","key":"779_CR42","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1124\/pr.108.00802","volume":"60","author":"LA Stoddart","year":"2008","unstructured":"Stoddart LA, Smith NJ, Milligan G (2008) International Union of Pharmacology. LXXI. Free fatty acid receptors FFA1,-2, and-3: pharmacology and pathophysiological functions. Pharmacol Rev 60(4):405\u2013417","journal-title":"Pharmacol Rev"},{"issue":"3","key":"779_CR43","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.trsl.2012.10.007","volume":"161","author":"BT Layden","year":"2013","unstructured":"Layden BT et al (2013) Short chain fatty acids and their receptors: new metabolic targets. Transl Res 161(3):131\u2013140","journal-title":"Transl Res"},{"issue":"22","key":"779_CR44","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1038\/sj.onc.1210407","volume":"26","author":"Z Goldsmith","year":"2007","unstructured":"Goldsmith Z, Dhanasekaran D (2007) G protein regulation of MAPK networks. Oncogene 26(22):3122\u20133142","journal-title":"Oncogene"},{"issue":"10","key":"779_CR45","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1248\/bpb.31.1847","volume":"31","author":"A Hirasawa","year":"2008","unstructured":"Hirasawa A et al (2008) Free fatty acid receptors and drug discovery. Biol Pharm Bull 31(10):1847\u20131851","journal-title":"Biol Pharm Bull"},{"issue":"13","key":"779_CR46","doi-asserted-by":"publisher","first-page":"11312","DOI":"10.1074\/jbc.M211609200","volume":"278","author":"AJ Brown","year":"2003","unstructured":"Brown AJ et al (2003) The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 278(13):11312\u201311319","journal-title":"J Biol Chem"},{"issue":"47","key":"779_CR47","doi-asserted-by":"publisher","first-page":"32913","DOI":"10.1074\/jbc.M805601200","volume":"283","author":"LA Stoddart","year":"2008","unstructured":"Stoddart LA et al (2008) Conserved polar residues in transmembrane domains V, VI, and VII of free fatty acid receptor 2 and free fatty acid receptor 3 are required for the binding and function of short chain fatty acids. J Biol Chem 283(47):32913\u201332924","journal-title":"J Biol Chem"},{"issue":"4","key":"779_CR48","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3109\/10799893.2012.692118","volume":"32","author":"S Seljeset","year":"2012","unstructured":"Seljeset S, Siehler S (2012) Receptor-specific regulation of ERK1\/2 activation by members of the \u201cfree fatty acid receptor\u201d family. J Recept Sig Transduct 32(4):196\u2013201","journal-title":"J Recept Sig Transduct"},{"issue":"4","key":"779_CR49","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.cell.2016.07.050","volume":"166","author":"P Sen","year":"2016","unstructured":"Sen P et al (2016) Epigenetic mechanisms of longevity and aging. Cell 166(4):822\u2013839","journal-title":"Cell"},{"issue":"9","key":"779_CR50","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tins.2018.05.005","volume":"41","author":"A Berson","year":"2018","unstructured":"Berson A et al (2018) Epigenetic regulation in neurodegenerative diseases. Trends Neurosci 41(9):587\u2013598","journal-title":"Trends Neurosci"},{"issue":"18","key":"779_CR51","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.1523\/JNEUROSCI.6119-09.2010","volume":"30","author":"A Jowaed","year":"2010","unstructured":"Jowaed A et al (2010) Methylation regulates alpha-synuclein expression and is decreased in Parkinson\u2019s disease patients\u2019 brains. J Neurosci 30(18):6355\u20136359","journal-title":"J Neurosci"},{"key":"779_CR52","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neuropharm.2014.01.038","volume":"80","author":"A Fischer","year":"2014","unstructured":"Fischer A (2014) Targeting histone-modifications in Alzheimer\u2019s disease. What is the evidence that this is a promising therapeutic avenue? Neuropharmacology 80:95\u2013102","journal-title":"Neuropharmacology"},{"issue":"2","key":"779_CR53","first-page":"166","volume":"3","author":"H-J Kim","year":"2011","unstructured":"Kim H-J, Bae S-C (2011) Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs. Amer J Trans Res 3(2):166","journal-title":"Amer J Trans Res"},{"key":"779_CR54","doi-asserted-by":"publisher","first-page":"869647","DOI":"10.5402\/2011\/869647","volume":"2011","author":"PV Licciardi","year":"2011","unstructured":"Licciardi PV, Ververis K, Karagiannis TC (2011) Histone Deacetylase Inhibition and Dietary Short-Chain Fatty Acids. ISRN Allergy 2011:869647","journal-title":"ISRN Allergy"},{"issue":"6","key":"779_CR55","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.nut.2009.07.006","volume":"26","author":"M Aoyama","year":"2010","unstructured":"Aoyama M, Kotani J, Usami M (2010) Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41\/GPR-43 pathways. Nutrition 26(6):653\u2013661","journal-title":"Nutrition"},{"issue":"6","key":"779_CR56","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1073\/pnas.1322269111","volume":"111","author":"PV Chang","year":"2014","unstructured":"Chang PV et al (2014) The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci U S A 111(6):2247\u20132252","journal-title":"Proc Natl Acad Sci U S A"},{"key":"779_CR57","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/bs.pmbts.2020.08.012","volume":"176","author":"M Bistoletti","year":"2020","unstructured":"Bistoletti M et al (2020) The microbiota-gut-brain axis: Focus on the fundamental communication pathways. Prog Mol Biol Transl Sci 176:43\u2013110","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"5","key":"779_CR58","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.clinthera.2015.03.002","volume":"37","author":"S El Aidy","year":"2015","unstructured":"El Aidy S, Dinan TG, Cryan JF (2015) Gut microbiota: the conductor in the orchestra of immune\u2013neuroendocrine communication. Clin Ther 37(5):954\u2013967","journal-title":"Clin Ther"},{"key":"779_CR59","doi-asserted-by":"publisher","first-page":"508738","DOI":"10.3389\/fendo.2020.00025","volume":"11","author":"YP Silva","year":"2020","unstructured":"Silva YP, Bernardi A, Frozza RL (2020) The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol 11:508738","journal-title":"Front Endocrinol"},{"issue":"4","key":"779_CR60","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","volume":"99","author":"JF Cryan","year":"2019","unstructured":"Cryan JF et al (2019) The Microbiota-Gut-Brain Axis. Physiol Rev 99(4):1877\u20132013","journal-title":"Physiol Rev"},{"issue":"5","key":"779_CR61","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/brain\/awaa096","volume":"143","author":"ML Arotcarena","year":"2020","unstructured":"Arotcarena ML et al (2020) Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates. Brain 143(5):1462\u20131475","journal-title":"Brain"},{"issue":"1","key":"779_CR62","doi-asserted-by":"publisher","first-page":"e13777","DOI":"10.1111\/nmo.13777","volume":"32","author":"L Leclair-Visonneau","year":"2020","unstructured":"Leclair-Visonneau L et al (2020) The gut in Parkinson\u2019s disease: Bottom-up, top-down, or neither? Neurogastroenterol Motil 32(1):e13777","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"779_CR63","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1152\/physrev.00018.2022","volume":"103","author":"KA Sharkey","year":"2023","unstructured":"Sharkey KA, Mawe GM (2023) The enteric nervous system. Physiol Rev 103(2):1487\u20131564","journal-title":"Physiol Rev"},{"issue":"4","key":"779_CR64","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/cphy.c130055","volume":"4","author":"KN Browning","year":"2014","unstructured":"Browning KN, Travagli RA (2014) Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions. Compr Physiol 4(4):1339","journal-title":"Compr Physiol"},{"issue":"11","key":"779_CR65","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nrgastro.2012.138","volume":"9","author":"BD Gulbransen","year":"2012","unstructured":"Gulbransen BD, Sharkey KA (2012) Novel functional roles for enteric glia in the gastrointestinal tract. Nat Rev Gastroenterol Hepatol 9(11):625\u2013632","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"779_CR66","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41575-021-00423-7","volume":"18","author":"L Seguella","year":"2021","unstructured":"Seguella L, Gulbransen BD (2021) Enteric glial biology, intercellular signalling and roles in gastrointestinal disease. Nat Rev Gastroenterol Hepatol 18(8):571\u2013587","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"779_CR67","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3390\/life11080732","volume":"11","author":"G Natale","year":"2021","unstructured":"Natale G et al (2021) The baseline structure of the enteric nervous system and its role in Parkinson\u2019s disease. Life 11(8):732","journal-title":"Life"},{"issue":"6","key":"779_CR68","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.3390\/biomedicines11061560","volume":"11","author":"M Montanari","year":"2023","unstructured":"Montanari M et al (2023) Beyond the microbiota: understanding the role of the enteric nervous system in Parkinson\u2019s disease from mice to human. Biomedicines 11(6):1560","journal-title":"Biomedicines"},{"issue":"8","key":"779_CR69","doi-asserted-by":"publisher","first-page":"7205","DOI":"10.3390\/ijms24087205","volume":"24","author":"M Chen","year":"2023","unstructured":"Chen M, Mor DE (2023) Gut-to-brain \u03b1-synuclein transmission in parkinson\u2019s disease: evidence for prion-like mechanisms. Int J Mol Sci 24(8):7205","journal-title":"Int J Mol Sci"},{"issue":"S11","key":"779_CR70","first-page":"S115","volume":"44","author":"E Hirsch","year":"1998","unstructured":"Hirsch E et al (1998) Glial cells and inflammation in Parkinson\u2019s disease: a role in neurodegeneration? Ann Neurol 44(S11):S115\u2013S120","journal-title":"Ann Neurol"},{"key":"779_CR71","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1007\/s00018-020-03584-x","volume":"77","author":"AV Domingues","year":"2020","unstructured":"Domingues AV et al (2020) Glial cells in Parkinson\u00b4 s disease: protective or deleterious? Cell Mol Life Sci 77:5171\u20135188","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"779_CR72","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41531-022-00295-x","volume":"8","author":"T Warnecke","year":"2022","unstructured":"Warnecke T et al (2022) Gastrointestinal involvement in Parkinson\u2019s disease: pathophysiology, diagnosis, and management. NPJ Park Dis 8(1):31","journal-title":"NPJ Park Dis"},{"issue":"s2","key":"779_CR73","doi-asserted-by":"publisher","first-page":"S331","DOI":"10.3233\/JPD-191729","volume":"9","author":"T Brudek","year":"2019","unstructured":"Brudek T (2019) Inflammatory bowel diseases and Parkinson\u2019s disease. J Parkinsons Dis 9(s2):S331\u2013S344","journal-title":"J Parkinsons Dis"},{"issue":"6","key":"779_CR74","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1053\/j.gastro.2014.09.040","volume":"147","author":"M Neunlist","year":"2014","unstructured":"Neunlist M et al (2014) Enteric glial cells: recent developments and future directions. Gastroenterology 147(6):1230\u20131237","journal-title":"Gastroenterology"},{"issue":"5","key":"779_CR75","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1053\/j.gastro.2010.01.053","volume":"138","author":"R Soret","year":"2010","unstructured":"Soret R et al (2010) Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats. Gastroenterology 138(5):1772-1782.e4","journal-title":"Gastroenterology"},{"issue":"11","key":"779_CR76","doi-asserted-by":"publisher","first-page":"G941","DOI":"10.1152\/ajpgi.00232.2015","volume":"310","author":"F Cossais","year":"2016","unstructured":"Cossais F et al (2016) Postnatal development of the myenteric glial network and its modulation by butyrate. Amer J Physiol-Gastrointest Liver Physiol 310(11):G941\u2013G951","journal-title":"Amer J Physiol-Gastrointest Liver Physiol"},{"issue":"10","key":"779_CR77","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1210\/en.2013-1142","volume":"154","author":"MK N\u00f8hr","year":"2013","unstructured":"N\u00f8hr MK et al (2013) GPR41\/FFAR3 and GPR43\/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology 154(10):3552\u20133564","journal-title":"Endocrinology"},{"issue":"6","key":"779_CR78","doi-asserted-by":"publisher","first-page":"G1415","DOI":"10.1152\/ajpgi.1998.275.6.G1415","volume":"275","author":"C Cherbut","year":"1998","unstructured":"Cherbut C et al (1998) Short-chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat. Amer J Physiol-Gastroint Liver Physiol 275(6):G1415\u2013G1422","journal-title":"Amer J Physiol-Gastroint Liver Physiol"},{"issue":"12","key":"779_CR79","doi-asserted-by":"publisher","first-page":"G1373","DOI":"10.1152\/ajpgi.00338.2011","volume":"302","author":"E Suply","year":"2012","unstructured":"Suply E et al (2012) Butyrate enemas enhance both cholinergic and nitrergic phenotype of myenteric neurons and neuromuscular transmission in newborn rat colon. Amer J Physiol-Gastroint Liver Physiol 302(12):G1373\u2013G1380","journal-title":"Amer J Physiol-Gastroint Liver Physiol"},{"issue":"9","key":"779_CR80","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.3390\/microorganisms10091838","volume":"10","author":"LM Dicks","year":"2022","unstructured":"Dicks LM (2022) Gut bacteria and neurotransmitters. Microorganisms 10(9):1838","journal-title":"Microorganisms"},{"key":"779_CR81","doi-asserted-by":"publisher","first-page":"336468","DOI":"10.3389\/fnins.2018.00049","volume":"12","author":"B Bonaz","year":"2018","unstructured":"Bonaz B, Bazin T, Pellissier S (2018) The vagus nerve at the interface of the microbiota-gut-brain axis. Front Neurosci 12:336468","journal-title":"Front Neurosci"},{"key":"779_CR82","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/bs.irn.2022.07.006","volume":"167","author":"KB Menees","year":"2022","unstructured":"Menees KB, Otero BA, Tansey MG (2022) Microbiome influences on neuro-immune interactions in neurodegenerative disease. Int Rev Neurobiol 167:25\u201357","journal-title":"Int Rev Neurobiol"},{"key":"779_CR83","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/978-1-4939-0897-4_5","volume":"817","author":"P Forsythe","year":"2014","unstructured":"Forsythe P, Bienenstock J, Kunze WA (2014) Vagal pathways for microbiome-brain-gut axis communication. Adv Exp Med Biol 817:115\u2013133","journal-title":"Adv Exp Med Biol"},{"key":"779_CR84","doi-asserted-by":"publisher","first-page":"6213","DOI":"10.2147\/JIR.S384949","volume":"15","author":"Y Han","year":"2022","unstructured":"Han Y et al (2022) Vagus nerve and underlying impact on the gut microbiota-brain axis in behavior and neurodegenerative diseases. J Inflam Res 15:6213\u20136230","journal-title":"J Inflam Res"},{"issue":"6","key":"779_CR85","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","volume":"128","author":"S Holmqvist","year":"2014","unstructured":"Holmqvist S et al (2014) Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol 128(6):805\u2013820","journal-title":"Acta Neuropathol"},{"key":"779_CR86","doi-asserted-by":"crossref","unstructured":"D\u00e9carie-Spain L, Hayes AM, Lauer LT, Kanoski SE (2024) The gut-brain axis and cognitive control: a role for the vagus nerve. In seminars in cell & developmental biology, Vol 156. Academic, pp 201\u2013209","DOI":"10.1016\/j.semcdb.2023.02.004"},{"issue":"7","key":"779_CR87","doi-asserted-by":"publisher","first-page":"750","DOI":"10.2174\/1389203720666190125105401","volume":"20","author":"Y Wu","year":"2019","unstructured":"Wu Y et al (2019) The role of neuropeptide Y and peptide YY in the development of obesity via gut-brain axis. Curr Protein Pept Sci 20(7):750\u2013758","journal-title":"Curr Protein Pept Sci"},{"key":"779_CR88","doi-asserted-by":"crossref","unstructured":"Thorsell A et al (2006) Neuropeptide Y in brain function. Handbook of Neurochemistry and Molecular Neurobiol, pp 523\u2013543","DOI":"10.1007\/978-0-387-30381-9_23"},{"issue":"10","key":"779_CR89","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrn3346","volume":"13","author":"JF Cryan","year":"2012","unstructured":"Cryan JF, Dinan TG (2012) Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13(10):701\u2013712","journal-title":"Nat Rev Neurosci"},{"key":"779_CR90","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.3389\/fmicb.2016.01934","volume":"7","author":"R Mazzoli","year":"2016","unstructured":"Mazzoli R, Pessione E (2016) The Neuro-endocrinological Role of Microbial Glutamate and GABA Signaling. Front Microbiol 7:1934","journal-title":"Front Microbiol"},{"issue":"5","key":"779_CR91","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.tins.2013.01.005","volume":"36","author":"JA Foster","year":"2013","unstructured":"Foster JA, Neufeld K-AM (2013) Gut\u2013brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 36(5):305\u2013312","journal-title":"Trends Neurosci"},{"issue":"25","key":"779_CR92","doi-asserted-by":"publisher","first-page":"6458","DOI":"10.1073\/pnas.1720017115","volume":"115","author":"F De Vadder","year":"2018","unstructured":"De Vadder F et al (2018) Gut microbiota regulates maturation of the adult enteric nervous system via enteric serotonin networks. Proc Natl Acad Sci U S A 115(25):6458\u20136463","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"779_CR93","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/glia.22772","volume":"63","author":"K Glebov","year":"2015","unstructured":"Glebov K et al (2015) Serotonin stimulates secretion of exosomes from microglia cells. Glia 63(4):626\u2013634","journal-title":"Glia"},{"issue":"2","key":"779_CR94","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/14737175.2020.1701437","volume":"20","author":"A Mulak","year":"2020","unstructured":"Mulak A (2020) An overview of the neuroendocrine system in Parkinson\u2019s disease: what is the impact on diagnosis and treatment? Expert Rev Neurother 20(2):127\u2013135","journal-title":"Expert Rev Neurother"},{"issue":"3","key":"779_CR95","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41385-020-00368-1","volume":"14","author":"A Jacobson","year":"2021","unstructured":"Jacobson A et al (2021) The intestinal neuro-immune axis: crosstalk between neurons, immune cells, and microbes. Mucosal Immunol 14(3):555\u2013565","journal-title":"Mucosal Immunol"},{"issue":"6408","key":"779_CR96","doi-asserted-by":"publisher","first-page":"eaat5236","DOI":"10.1126\/science.aat5236","volume":"361","author":"MM Kaelberer","year":"2018","unstructured":"Kaelberer MM et al (2018) A gut-brain neural circuit for nutrient sensory transduction. Science 361(6408):eaat5236","journal-title":"Science"},{"key":"779_CR97","doi-asserted-by":"publisher","first-page":"34477","DOI":"10.1038\/srep34477","volume":"6","author":"SG Chen","year":"2016","unstructured":"Chen SG et al (2016) Exposure to the Functional Bacterial Amyloid Protein Curli Enhances Alpha-Synuclein Aggregation in Aged Fischer 344 Rats and Caenorhabditis elegans. Sci Rep 6:34477","journal-title":"Sci Rep"},{"key":"779_CR98","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/B978-0-12-815950-7.00027-8","volume-title":"Genetics, neurology, behavior, and diet in Parkinson's disease","author":"T Varanita","year":"2020","unstructured":"Varanita T, Bubacco L (2020) Alpha-synuclein and neuroinflammation in Parkinson\u2019s disease. Genetics, neurology, behavior, and diet in Parkinson\u2019s disease. Elsevier, pp 431\u2013446"},{"key":"779_CR99","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1038\/ncomms2534","volume":"4","author":"C Kim","year":"2013","unstructured":"Kim C et al (2013) Neuron-released oligomeric \u03b1-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat Commun 4:1562","journal-title":"Nat Commun"},{"issue":"376","key":"779_CR100","first-page":"ra45","volume":"8","author":"SG Daniele","year":"2015","unstructured":"Daniele SG et al (2015) Activation of MyD88-dependent TLR1\/2 signaling by misfolded \u03b1-synuclein, a protein linked to neurodegenerative disorders. Sci Sig 8(376):ra45","journal-title":"Sci Sig"},{"issue":"4","key":"779_CR101","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s13167-023-00340-6","volume":"14","author":"Y Luo","year":"2023","unstructured":"Luo Y et al (2023) Causal relationship between gut Prevotellaceae and risk of sepsis: a two-sample Mendelian randomization and clinical retrospective study in the framework of predictive, preventive, and personalized medicine. EPMA Journal 14(4):697\u2013711","journal-title":"EPMA Journal"},{"issue":"37","key":"779_CR102","doi-asserted-by":"publisher","first-page":"10609","DOI":"10.3748\/wjg.v21.i37.10609","volume":"21","author":"A Mulak","year":"2015","unstructured":"Mulak A, Bonaz B (2015) Brain-gut-microbiota axis in Parkinson\u2019s disease. World J Gastroenterol 21(37):10609\u201310620","journal-title":"World J Gastroenterol"},{"issue":"5","key":"779_CR103","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41575-019-0261-4","volume":"17","author":"JF Burgue\u00f1o","year":"2020","unstructured":"Burgue\u00f1o JF, Abreu MT (2020) Epithelial Toll-like receptors and their role in gut homeostasis and disease. Nat Rev Gastroenterol Hepatol 17(5):263\u2013278","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"779_CR104","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40035-021-00271-0","volume":"10","author":"AM Gorecki","year":"2021","unstructured":"Gorecki AM, Anyaegbu CC, Anderton RS (2021) TLR2 and TLR4 in Parkinson\u2019s disease pathogenesis: The environment takes a toll on the gut. Trans Neurodegener 10(1):47","journal-title":"Trans Neurodegener"},{"issue":"1","key":"779_CR105","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/microorganisms7010014","volume":"7","author":"E Rinninella","year":"2019","unstructured":"Rinninella E et al (2019) What is the Healthy Gut Microbiota Composition? Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms 7(1):14","journal-title":"Microorganisms"},{"issue":"11","key":"779_CR106","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1042\/BCJ20160510","volume":"474","author":"E Thursby","year":"2017","unstructured":"Thursby E, Juge N (2017) Introduction to the human gut microbiota. Biochem J 474(11):1823\u20131836","journal-title":"Biochem J"},{"issue":"9","key":"779_CR107","doi-asserted-by":"publisher","first-page":"8061","DOI":"10.3390\/ijms24098061","volume":"24","author":"S Calabr\u00f2","year":"2023","unstructured":"Calabr\u00f2 S et al (2023) Impact of gut microbiota on the peripheral nervous system in physiological, regenerative and pathological conditions. Int J Mol Sci 24(9):8061","journal-title":"Int J Mol Sci"},{"issue":"3","key":"779_CR108","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1365-2982.2010.01664.x","volume":"23","author":"JF Cryan","year":"2011","unstructured":"Cryan JF, O\u2019Mahony SM (2011) The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil 23(3):187\u2013192","journal-title":"Neurogastroenterol Motil"},{"key":"779_CR109","first-page":"14","volume":"4","author":"N Shi","year":"2017","unstructured":"Shi N et al (2017) Interaction between the gut microbiome and mucosal immune system. Mil Med Res 4:14","journal-title":"Mil Med Res"},{"key":"779_CR110","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.bbi.2016.10.011","volume":"60","author":"R Mayerhofer","year":"2017","unstructured":"Mayerhofer R et al (2017) Diverse action of lipoteichoic acid and lipopolysaccharide on neuroinflammation, blood-brain barrier disruption, and anxiety in mice. Brain Behav Immun 60:174\u2013187","journal-title":"Brain Behav Immun"},{"issue":"5","key":"779_CR111","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.tins.2013.01.005","volume":"36","author":"JA Foster","year":"2013","unstructured":"Foster JA, McVey Neufeld KA (2013) Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 36(5):305\u2013312","journal-title":"Trends Neurosci"},{"issue":"5","key":"779_CR112","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.tim.2014.03.001","volume":"22","author":"AW Walker","year":"2014","unstructured":"Walker AW et al (2014) Phylogeny, culturing, and metagenomics of the human gut microbiota. Trends Microbiol 22(5):267\u2013274","journal-title":"Trends Microbiol"},{"issue":"3","key":"779_CR113","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s13760-023-02195-0","volume":"123","author":"G Babacan Yildiz","year":"2023","unstructured":"Babacan Yildiz G et al (2023) Altered gut microbiota in patients with idiopathic Parkinson\u2019s disease: an age\u2013sex matched case\u2013control study. Acta Neurol Belg 123(3):999\u20131009","journal-title":"Acta Neurol Belg"},{"issue":"1","key":"779_CR114","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40035-023-00392-8","volume":"12","author":"X Zhang","year":"2023","unstructured":"Zhang X, Tang B, Guo J (2023) Parkinson\u2019s disease and gut microbiota: from clinical to mechanistic and therapeutic studies. Transl Neurodegener 12(1):59","journal-title":"Transl Neurodegener"},{"issue":"9","key":"779_CR115","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3390\/nu15092211","volume":"15","author":"W Fusco","year":"2023","unstructured":"Fusco W et al (2023) Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota. Nutrients 15(9):2211","journal-title":"Nutrients"},{"key":"779_CR116","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/5584_2018_312","volume":"1125","author":"M Selma-Royo","year":"2019","unstructured":"Selma-Royo M et al (2019) Shaping Microbiota During the First 1000 Days of Life. Adv Exp Med Biol 1125:3\u201324","journal-title":"Adv Exp Med Biol"},{"key":"779_CR117","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3389\/fmicb.2018.00890","volume":"9","author":"I Garcia-Mantrana","year":"2018","unstructured":"Garcia-Mantrana I et al (2018) Shifts on Gut Microbiota Associated to Mediterranean Diet Adherence and Specific Dietary Intakes on General Adult Population. Front Microbiol 9:890","journal-title":"Front Microbiol"},{"issue":"3","key":"779_CR118","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/00004836-200603000-00015","volume":"40","author":"JM Wong","year":"2006","unstructured":"Wong JM et al (2006) Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 40(3):235\u2013243","journal-title":"J Clin Gastroenterol"},{"key":"779_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-016-0708-5","volume":"16","author":"T Odamaki","year":"2016","unstructured":"Odamaki T et al (2016) Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol 16:1\u201312","journal-title":"BMC Microbiol"},{"issue":"3","key":"779_CR120","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3390\/d5030627","volume":"5","author":"A Biddle","year":"2013","unstructured":"Biddle A et al (2013) Untangling the genetic basis of fibrolytic specialization by Lachnospiraceae and Ruminococcaceae in diverse gut communities. Diversity 5(3):627\u2013640","journal-title":"Diversity"},{"issue":"9","key":"779_CR121","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1038\/s41396-021-00937-7","volume":"15","author":"N Tsukuda","year":"2021","unstructured":"Tsukuda N et al (2021) Key bacterial taxa and metabolic pathways affecting gut short-chain fatty acid profiles in early life. ISME J 15(9):2574\u20132590","journal-title":"ISME J"},{"issue":"9","key":"779_CR122","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41575-022-00605-x","volume":"19","author":"TS Ghosh","year":"2022","unstructured":"Ghosh TS, Shanahan F, O\u2019Toole PW (2022) The gut microbiome as a modulator of healthy ageing. Nat Rev Gastroenterol Hepatol 19(9):565\u2013584","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"21","key":"779_CR123","doi-asserted-by":"publisher","first-page":"fnv176","DOI":"10.1093\/femsle\/fnv176","volume":"362","author":"D Rios-Covian","year":"2015","unstructured":"Rios-Covian D et al (2015) Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis. FEMS Microbiol Lett 362(21):fnv176","journal-title":"FEMS Microbiol Lett"},{"key":"779_CR124","doi-asserted-by":"crossref","unstructured":"Guo B, Zhang J, Zhang W, Chen F, Liu B (2023) Gut microbiota-derived short chain fatty acids act as mediators of the gut\u2013brain axis targeting age-related neurodegenerative disorders: a narrative review. Critical reviews in food science and nutrition, 1\u201322","DOI":"10.1080\/10408398.2023.2272769"},{"issue":"1","key":"779_CR125","doi-asserted-by":"publisher","first-page":"11939","DOI":"10.1038\/ncomms11939","volume":"7","author":"T Matsuki","year":"2016","unstructured":"Matsuki T et al (2016) A key genetic factor for fucosyllactose utilization affects infant gut microbiota development. Nat Commun 7(1):11939","journal-title":"Nat Commun"},{"issue":"5","key":"779_CR126","doi-asserted-by":"publisher","first-page":"449","DOI":"10.4161\/gmic.21214","volume":"3","author":"S Fukuda","year":"2012","unstructured":"Fukuda S et al (2012) Acetate-producing bifidobacteria protect the host from enteropathogenic infection via carbohydrate transporters. Gut Microbes 3(5):449\u2013454","journal-title":"Gut Microbes"},{"key":"779_CR127","doi-asserted-by":"publisher","first-page":"103293","DOI":"10.1016\/j.ebiom.2021.103293","volume":"66","author":"S Deleu","year":"2021","unstructured":"Deleu S et al (2021) Short chain fatty acids and its producing organisms: An overlooked therapy for IBD? EBioMedicine 66:103293","journal-title":"EBioMedicine"},{"issue":"6","key":"779_CR128","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/ismej.2014.14","volume":"8","author":"N Reichardt","year":"2014","unstructured":"Reichardt N et al (2014) Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. ISME J 8(6):1323\u20131335","journal-title":"ISME J"},{"issue":"1","key":"779_CR129","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cmet.2016.06.013","volume":"24","author":"F De Vadder","year":"2016","unstructured":"De Vadder F et al (2016) Microbiota-produced succinate improves glucose homeostasis via intestinal gluconeogenesis. Cell Metab 24(1):151\u2013157","journal-title":"Cell Metab"},{"issue":"11","key":"779_CR130","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1038\/ismej.2014.63","volume":"8","author":"A Salonen","year":"2014","unstructured":"Salonen A et al (2014) Impact of diet and individual variation on intestinal microbiota composition and fermentation products in obese men. ISME J 8(11):2218\u20132230","journal-title":"ISME J"},{"issue":"12","key":"779_CR131","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.1128\/JB.00137-06","volume":"188","author":"KP Scott","year":"2006","unstructured":"Scott KP et al (2006) Whole-genome transcription profiling reveals genes up-regulated by growth on fucose in the human gut bacterium \u201cRoseburia inulinivorans.\u201d J Bacteriol 188(12):4340\u20134349","journal-title":"J Bacteriol"},{"key":"779_CR132","doi-asserted-by":"publisher","first-page":"1103836","DOI":"10.3389\/fmicb.2022.1103836","volume":"13","author":"V Singh","year":"2023","unstructured":"Singh V et al (2023) Butyrate producers, \u201cThe Sentinel of Gut\u201d: Their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics. Front Microbiol 13:1103836","journal-title":"Front Microbiol"},{"key":"779_CR133","doi-asserted-by":"publisher","first-page":"660920","DOI":"10.3389\/fmicb.2021.660920","volume":"12","author":"JL Maturana","year":"2021","unstructured":"Maturana JL, C\u00e1rdenas JP (2021) Insights on the Evolutionary Genomics of the Blautia Genus: Potential New Species and Genetic Content Among Lineages. Front Microbiol 12:660920","journal-title":"Front Microbiol"},{"issue":"2","key":"779_CR134","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1462-2920.2009.02066.x","volume":"12","author":"P Louis","year":"2010","unstructured":"Louis P et al (2010) Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA: acetate CoA-transferase gene. Environ Microbiol 12(2):304\u2013314","journal-title":"Environ Microbiol"},{"key":"779_CR135","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3389\/fmicb.2018.00346","volume":"9","author":"R Mart\u00edn","year":"2018","unstructured":"Mart\u00edn R, Berm\u00fadez-Humar\u00e1n LG, Langella P (2018) Searching for the Bacterial Effector: The Example of the Multi-Skilled Commensal Bacterium Faecalibacterium prausnitzii. Front Microbiol 9:346","journal-title":"Front Microbiol"},{"issue":"8","key":"779_CR136","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1136\/gutjnl-2013-304833","volume":"63","author":"K Machiels","year":"2014","unstructured":"Machiels K et al (2014) A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 63(8):1275\u20131283","journal-title":"Gut"},{"key":"779_CR137","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.3389\/fmicb.2016.01945","volume":"7","author":"S Anand","year":"2016","unstructured":"Anand S, Kaur H, Mande SS (2016) Comparative In silico Analysis of Butyrate Production Pathways in Gut Commensals and Pathogens. Front Microbiol 7:1945","journal-title":"Front Microbiol"},{"key":"779_CR138","doi-asserted-by":"publisher","first-page":"e00889","DOI":"10.1128\/mBio.00889-14","volume":"5","author":"M Vital","year":"2014","unstructured":"Vital M, Howe A, Tiedje J (2014) Revealing the bacterial butyrate synthesis pathways by analyzing (meta) genomic data. MBio 5:e00889-e914","journal-title":"MBio"},{"issue":"2","key":"779_CR139","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3109\/00365528809103964","volume":"23","author":"HS Rasmussen","year":"1988","unstructured":"Rasmussen HS, Holtug K, Mortensen P (1988) Degradation of amino acids to short-chain fatty acids in humans: an in vitro study. Scand J Gastroenterol 23(2):178\u2013182","journal-title":"Scand J Gastroenterol"},{"key":"779_CR140","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fnut.2018.00046","volume":"5","author":"E \u00d6zcan","year":"2018","unstructured":"\u00d6zcan E, Sela DA (2018) Inefficient metabolism of the human milk oligosaccharides lacto-N-tetraose and lacto-N-neotetraose shifts Bifidobacterium longum subsp. infantis physiology. Front Nutr 5:46","journal-title":"Front Nutr"},{"issue":"1","key":"779_CR141","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1038\/s41598-022-07904-y","volume":"12","author":"C Walsh","year":"2022","unstructured":"Walsh C et al (2022) Human milk oligosaccharide-sharing by a consortium of infant derived Bifidobacterium species. Sci Rep 12(1):4143","journal-title":"Sci Rep"},{"key":"779_CR142","doi-asserted-by":"publisher","first-page":"244135","DOI":"10.3389\/fmicb.2017.00095","volume":"8","author":"C Schwab","year":"2017","unstructured":"Schwab C et al (2017) Trophic interactions of infant bifidobacteria and Eubacterium hallii during L-fucose and fucosyllactose degradation. Front Microbiol 8:244135","journal-title":"Front Microbiol"},{"issue":"9","key":"779_CR143","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/mds.28119","volume":"35","author":"H Nishiwaki","year":"2020","unstructured":"Nishiwaki H et al (2020) Meta-Analysis of Gut Dysbiosis in Parkinson\u2019s Disease. Mov Disord 35(9):1626\u20131635","journal-title":"Mov Disord"},{"issue":"1","key":"779_CR144","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41531-021-00156-z","volume":"7","author":"S Romano","year":"2021","unstructured":"Romano S et al (2021) Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Park Dis 7(1):27","journal-title":"NPJ Park Dis"},{"key":"779_CR145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2021.11.017","volume":"94","author":"TS Toh","year":"2022","unstructured":"Toh TS et al (2022) Gut microbiome in Parkinson\u2019s disease: New insights from meta-analysis. Parkinsonism Relat Disord 94:1\u20139","journal-title":"Parkinsonism Relat Disord"},{"key":"779_CR146","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41531-020-0112-6","volume":"6","author":"ZD Wallen","year":"2020","unstructured":"Wallen ZD et al (2020) Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens. NPJ Parkinsons Dis 6:11","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"779_CR147","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41467-019-08294-y","volume":"10","author":"SP van Kessel","year":"2019","unstructured":"van Kessel SP et al (2019) Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson\u2019s disease. Nat Commun 10(1):310","journal-title":"Nat Commun"},{"key":"779_CR148","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fneur.2020.00137","volume":"11","author":"T Ren","year":"2020","unstructured":"Ren T et al (2020) Gut Microbiota Altered in Mild Cognitive Impairment Compared With Normal Cognition in Sporadic Parkinson\u2019s Disease. Front Neurol 11:137","journal-title":"Front Neurol"},{"key":"779_CR149","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41531-019-0100-x","volume":"5","author":"S Weis","year":"2019","unstructured":"Weis S et al (2019) Effect of Parkinson\u2019s disease and related medications on the composition of the fecal bacterial microbiota. NPJ Parkinsons Dis 5:28","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"779_CR150","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13024-021-00427-6","volume":"16","author":"VTE Aho","year":"2021","unstructured":"Aho VTE et al (2021) Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson\u2019s disease. Mol Neurodegener 16(1):6","journal-title":"Mol Neurodegener"},{"issue":"2","key":"779_CR151","first-page":"117","volume":"57","author":"E Cassani","year":"2011","unstructured":"Cassani E et al (2011) Use of probiotics for the treatment of constipation in Parkinson\u2019s disease patients. Minerva Gastroenterol Dietol 57(2):117\u2013121","journal-title":"Minerva Gastroenterol Dietol"},{"issue":"1","key":"779_CR152","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41531-023-00587-w","volume":"10","author":"L-C Shih","year":"2024","unstructured":"Shih L-C et al (2024) Unravelling the mechanisms of underweight in Parkinson\u2019s disease by investigating into the role of gut microbiome. NPJ Park Dis 10(1):28","journal-title":"NPJ Park Dis"},{"issue":"3","key":"779_CR153","doi-asserted-by":"publisher","first-page":"103908","DOI":"10.1016\/j.isci.2022.103908","volume":"25","author":"DP AmorimNeto","year":"2022","unstructured":"AmorimNeto DP et al (2022) Akkermansia muciniphila induces mitochondrial calcium overload and \u03b1 -synuclein aggregation in an enteroendocrine cell line. iScience 25(3):103908","journal-title":"iScience"},{"issue":"3","key":"779_CR154","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3390\/brainsci14030238","volume":"14","author":"C-M Qiao","year":"2024","unstructured":"Qiao C-M et al (2024) Akkermansia muciniphila Is Beneficial to a Mouse Model of Parkinson\u2019s Disease, via Alleviated Neuroinflammation and Promoted Neurogenesis, with Involvement of SCFAs. Brain Sci 14(3):238","journal-title":"Brain Sci"},{"issue":"12","key":"779_CR155","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.3748\/wjg.v17.i12.1519","volume":"17","author":"RB Canani","year":"2011","unstructured":"Canani RB et al (2011) Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol 17(12):1519\u20131528","journal-title":"World J Gastroenterol"},{"issue":"6","key":"779_CR156","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mSystems.00797-20","volume":"5","author":"H Nishiwaki","year":"2020","unstructured":"Nishiwaki H et al (2020) Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson\u2019s Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder. mSystems 5(6):10\u2013128","journal-title":"mSystems"},{"issue":"8","key":"779_CR157","doi-asserted-by":"publisher","first-page":"e848","DOI":"10.1212\/WNL.0000000000013225","volume":"98","author":"S-J Chen","year":"2022","unstructured":"Chen S-J et al (2022) Association of fecal and plasma levels of short-chain fatty acids with gut microbiota and clinical severity in patients with Parkinson disease. Neurology 98(8):e848\u2013e858","journal-title":"Neurology"},{"key":"779_CR158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-021-00427-6","volume":"16","author":"VT Aho","year":"2021","unstructured":"Aho VT et al (2021) Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson\u2019s disease. Mol Neurodegener 16:1\u201314","journal-title":"Mol Neurodegener"},{"issue":"1","key":"779_CR159","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-48775-0","volume":"9","author":"M M\u00fcller","year":"2019","unstructured":"M\u00fcller M et al (2019) Circulating but not faecal short-chain fatty acids are related to insulin sensitivity, lipolysis and GLP-1 concentrations in humans. Sci Rep 9(1):1\u20139","journal-title":"Sci Rep"},{"key":"779_CR160","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.tifs.2020.02.026","volume":"100","author":"Y Xu","year":"2020","unstructured":"Xu Y et al (2020) Dynamic balancing of intestinal short-chain fatty acids: The crucial role of bacterial metabolism. Trends Food Sci Technol 100:118\u2013130","journal-title":"Trends Food Sci Technol"},{"issue":"8","key":"779_CR161","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1080\/10408398.2016.1245650","volume":"58","author":"J Hu","year":"2018","unstructured":"Hu J et al (2018) Short-chain fatty acids in control of energy metabolism. Crit Rev Food Sci Nutr 58(8):1243\u20131249","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"5","key":"779_CR162","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3920\/BM2020.0057","volume":"11","author":"E Blaak","year":"2020","unstructured":"Blaak E et al (2020) Short chain fatty acids in human gut and metabolic health. Beneficial microbes 11(5):411\u2013455","journal-title":"Beneficial microbes"},{"issue":"6","key":"779_CR163","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/mds.28016","volume":"35","author":"C Shin","year":"2020","unstructured":"Shin C et al (2020) Plasma Short-Chain Fatty Acids in Patients With Parkinson\u2019s Disease. Mov Disord 35(6):1021\u20131027","journal-title":"Mov Disord"},{"issue":"8","key":"779_CR164","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1002\/mds.29063","volume":"37","author":"X Yang","year":"2022","unstructured":"Yang X et al (2022) Parkinson\u2019s disease is associated with impaired gut-blood barrier for short-chain fatty acids. Mov Disord 37(8):1634\u20131643","journal-title":"Mov Disord"},{"issue":"1","key":"779_CR165","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12883-021-02544-7","volume":"22","author":"G Wu","year":"2022","unstructured":"Wu G et al (2022) Serum short-chain fatty acids and its correlation with motor and non-motor symptoms in Parkinson\u2019s disease patients. BMC Neurol 22(1):13","journal-title":"BMC Neurol"},{"key":"779_CR166","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cca.2020.08.005","volume":"510","author":"S Kumari","year":"2020","unstructured":"Kumari S et al (2020) Identification of potential urine biomarkers in idiopathic parkinson\u2019s disease using NMR. Clin Chim Acta 510:442\u2013449","journal-title":"Clin Chim Acta"},{"issue":"5","key":"779_CR167","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s10072-019-04143-4","volume":"41","author":"S Kumari","year":"2020","unstructured":"Kumari S et al (2020) Quantitative metabolomics of saliva using proton NMR spectroscopy in patients with Parkinson\u2019s disease and healthy controls. Neurol Sci 41(5):1201\u20131210","journal-title":"Neurol Sci"},{"issue":"1","key":"779_CR168","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/mds.27105","volume":"33","author":"A Heintz-Buschart","year":"2018","unstructured":"Heintz-Buschart A et al (2018) The nasal and gut microbiome in Parkinson\u2019s disease and idiopathic rapid eye movement sleep behavior disorder. Mov Disord 33(1):88\u201398","journal-title":"Mov Disord"},{"issue":"2","key":"779_CR169","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3390\/biomedicines9020167","volume":"9","author":"T Ishii","year":"2021","unstructured":"Ishii T et al (2021) Oral administration of probiotic bifidobacterium breve improves facilitation of hippocampal memory extinction via restoration of aberrant higher induction of neuropsin in an MPTP-induced mouse model of parkinson\u2019s disease. Biomedicines 9(2):167","journal-title":"Biomedicines"},{"issue":"3","key":"779_CR170","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ana.25982","volume":"89","author":"AH Tan","year":"2021","unstructured":"Tan AH et al (2021) Gut microbial ecosystem in parkinson disease: new clinicobiological insights from multi-omics. Ann Neurol 89(3):546\u2013559","journal-title":"Ann Neurol"},{"key":"779_CR171","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1749-6632.2009.05115.x","volume":"1184","author":"BF Boeve","year":"2010","unstructured":"Boeve BF (2010) REM sleep behavior disorder: Updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann N Y Acad Sci 1184:15\u201354","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"779_CR172","doi-asserted-by":"publisher","first-page":"357","DOI":"10.14336\/AD.2023.0518","volume":"15","author":"P Zhang","year":"2024","unstructured":"Zhang P et al (2024) Relationships Between Rapid Eye Movement Sleep Behavior Disorder and Parkinson\u2019s Disease: Indication from Gut Microbiota Alterations. Aging Dis 15(1):357","journal-title":"Aging Dis"},{"issue":"1","key":"779_CR173","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41522-021-00242-3","volume":"7","author":"Y Yan","year":"2021","unstructured":"Yan Y et al (2021) Gut microbiota and metabolites of \u03b1-synuclein transgenic monkey models with early stage of Parkinson\u2019s disease. NPJ Biofilms Microbiomes 7(1):69","journal-title":"NPJ Biofilms Microbiomes"},{"key":"779_CR174","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.parkreldis.2020.01.009","volume":"72","author":"JD Jones","year":"2020","unstructured":"Jones JD et al (2020) Gastrointestinal symptoms are predictive of trajectories of cognitive functioning in de novo Parkinson\u2019s disease. Parkinsonism Relat Disord 72:7\u201312","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"779_CR175","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0126-x","volume":"50","author":"C Chelakkot","year":"2018","unstructured":"Chelakkot C, Ghim J, Ryu SH (2018) Mechanisms regulating intestinal barrier integrity and its pathological implications. Exp Mol Med 50(8):1\u20139","journal-title":"Exp Mol Med"},{"issue":"1","key":"779_CR176","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/mi.2016.75","volume":"10","author":"MY Zeng","year":"2017","unstructured":"Zeng MY, Inohara N, Nu\u00f1ez G (2017) Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol 10(1):18\u201326","journal-title":"Mucosal Immunol"},{"issue":"8","key":"779_CR177","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1136\/gutjnl-2019-318427","volume":"68","author":"M Camilleri","year":"2019","unstructured":"Camilleri M (2019) Leaky gut: mechanisms, measurement and clinical implications in humans. Gut 68(8):1516\u20131526","journal-title":"Gut"},{"key":"779_CR178","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40478-015-0196-0","volume":"3","author":"T Clairembault","year":"2015","unstructured":"Clairembault T et al (2015) Structural alterations of the intestinal epithelial barrier in Parkinson\u2019s disease. Acta Neuropathol Commun 3:12","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"779_CR179","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/gutjnl-2018-316844","volume":"68","author":"P Perez-Pardo","year":"2019","unstructured":"Perez-Pardo P et al (2019) Role of TLR4 in the gut-brain axis in Parkinson\u2019s disease: a translational study from men to mice. Gut 68(5):829\u2013843","journal-title":"Gut"},{"issue":"4","key":"779_CR180","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1021\/acschemneuro.2c00730","volume":"14","author":"S Kumari","year":"2023","unstructured":"Kumari S, Taliyan R, Dubey SK (2023) Comprehensive review on potential signaling pathways involving the transfer of \u03b1-synuclein from the gut to the brain that leads to Parkinson\u2019s disease. ACS Chem Neurosci 14(4):590\u2013602","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"779_CR181","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/mds.29620","volume":"39","author":"Y Yang","year":"2024","unstructured":"Yang Y et al (2024) Erythrocytic \u03b1-Synuclein and the Gut Microbiome: Kindling of the Gut-Brain Axis in Parkinson\u2019s Disease. Mov Disord 39(1):40\u201352","journal-title":"Mov Disord"},{"issue":"1","key":"779_CR182","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41531-021-00263-x","volume":"8","author":"C Pellegrini","year":"2022","unstructured":"Pellegrini C et al (2022) (2022) Enteric \u03b1-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson\u2019s disease before brain pathology. NPJ Park Dis 8(1):9","journal-title":"NPJ Park Dis"},{"key":"779_CR183","doi-asserted-by":"publisher","first-page":"101812","DOI":"10.1016\/j.arr.2022.101812","volume":"84","author":"JCC Dos Santos","year":"2023","unstructured":"Dos Santos JCC et al (2023) Role of enteric glia and microbiota-gut-brain axis in parkinson disease pathogenesis. Ageing Res Rev 84:101812","journal-title":"Ageing Res Rev"},{"issue":"3","key":"779_CR184","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2174\/1389557522666220622111501","volume":"23","author":"I Neri","year":"2023","unstructured":"Neri I et al (2023) Microbiota-Gut-Brain axis in neurological disorders: From leaky barriers microanatomical changes to biochemical processes. Mini Rev Med Chem 23(3):307\u2013319","journal-title":"Mini Rev Med Chem"},{"issue":"8","key":"779_CR185","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.4049\/jimmunol.1700105","volume":"199","author":"L Zheng","year":"2017","unstructured":"Zheng L et al (2017) Microbial-derived butyrate promotes epithelial barrier function through IL-10 receptor\u2013dependent repression of claudin-2. J Immunol 199(8):2976\u20132984","journal-title":"J Immunol"},{"issue":"9","key":"779_CR186","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3945\/jn.109.104638","volume":"139","author":"L Peng","year":"2009","unstructured":"Peng L et al (2009) Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr 139(9):1619\u20131625","journal-title":"J Nutr"},{"key":"779_CR187","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1007\/s10620-012-2259-4","volume":"57","author":"H-B Wang","year":"2012","unstructured":"Wang H-B et al (2012) Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription. Dig Dis Sci 57:3126\u20133135","journal-title":"Dig Dis Sci"},{"issue":"3","key":"779_CR188","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1091\/mbc.e08-06-0566","volume":"20","author":"SK Harten","year":"2009","unstructured":"Harten SK et al (2009) Regulation of renal epithelial tight junctions by the von Hippel-Lindau tumor suppressor gene involves occludin and claudin 1 and is independent of E-cadherin. Mol Biol Cell 20(3):1089\u20131101","journal-title":"Mol Biol Cell"},{"issue":"12","key":"779_CR189","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1158\/1541-7786.692.2.12","volume":"2","author":"M Bordin","year":"2004","unstructured":"Bordin M et al (2004) Histone deacetylase inhibitors up-regulate the expression of tight junction proteins. Mol Cancer Res 2(12):692\u2013701","journal-title":"Mol Cancer Res"},{"issue":"6","key":"779_CR190","doi-asserted-by":"publisher","first-page":"e0179586","DOI":"10.1371\/journal.pone.0179586","volume":"12","author":"H Yan","year":"2017","unstructured":"Yan H, Ajuwon KM (2017) Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathway. PLoS ONE 12(6):e0179586","journal-title":"PLoS ONE"},{"issue":"3","key":"779_CR191","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3390\/biology10030205","volume":"10","author":"X Huang","year":"2021","unstructured":"Huang X et al (2021) Butyrate alleviates cytokine-induced barrier dysfunction by modifying claudin-2 levels. Biology 10(3):205","journal-title":"Biology"},{"key":"779_CR192","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12263-019-0626-x","volume":"14","author":"H Diao","year":"2019","unstructured":"Diao H et al (2019) Gastric infusion of short-chain fatty acids can improve intestinal barrier function in weaned piglets. Genes Nutr 14:1\u201316","journal-title":"Genes Nutr"},{"key":"779_CR193","doi-asserted-by":"publisher","first-page":"650313","DOI":"10.3389\/fphys.2021.650313","volume":"12","author":"D P\u00e9rez-Reytor","year":"2021","unstructured":"P\u00e9rez-Reytor D et al (2021) Use of short-chain fatty acids for the recovery of the intestinal epithelial barrier affected by bacterial toxins. Front Physiol 12:650313","journal-title":"Front Physiol"},{"issue":"4","key":"779_CR194","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1128\/JB.180.4.767-772.1998","volume":"180","author":"AJ Roe","year":"1998","unstructured":"Roe AJ et al (1998) Perturbation of anion balance during inhibition of growth of Escherichia coli by weak acids. J Bacteriol 180(4):767\u2013772","journal-title":"J Bacteriol"},{"issue":"1","key":"779_CR195","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/cphy.c170014","volume":"8","author":"S Sivaprakasam","year":"2017","unstructured":"Sivaprakasam S et al (2017) Short-chain fatty acid transporters: role in colonic homeostasis. Compr Physiol 8(1):299","journal-title":"Compr Physiol"},{"issue":"1","key":"779_CR196","doi-asserted-by":"publisher","first-page":"6734","DOI":"10.1038\/ncomms7734","volume":"6","author":"L Macia","year":"2015","unstructured":"Macia L et al (2015) Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat Commun 6(1):6734","journal-title":"Nat Commun"},{"issue":"6","key":"779_CR197","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.cell.2015.10.072","volume":"163","author":"R Nowarski","year":"2015","unstructured":"Nowarski R et al (2015) Epithelial IL-18 equilibrium controls barrier function in colitis. Cell 163(6):1444\u20131456","journal-title":"Cell"},{"key":"779_CR198","doi-asserted-by":"publisher","first-page":"134516","DOI":"10.1016\/j.neulet.2019.134516","volume":"712","author":"S Sharma","year":"2019","unstructured":"Sharma S, Awasthi A, Singh S (2019) Altered gut microbiota and intestinal permeability in Parkinson\u2019s disease: Pathological highlight to management. Neurosci Lett 712:134516","journal-title":"Neurosci Lett"},{"issue":"1","key":"779_CR199","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.immuni.2013.12.007","volume":"40","author":"N Singh","year":"2014","unstructured":"Singh N et al (2014) Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40(1):128\u2013139","journal-title":"Immunity"},{"key":"779_CR200","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00535-016-1242-9","volume":"52","author":"M Sun","year":"2017","unstructured":"Sun M et al (2017) Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases. J Gastroenterol 52:1\u20138","journal-title":"J Gastroenterol"},{"issue":"2","key":"779_CR201","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1042\/BJ20082222","volume":"420","author":"N Burger-van Paassen","year":"2009","unstructured":"Burger-van Paassen N et al (2009) The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection. Biochemical Journal 420(2):211\u2013219","journal-title":"Biochemical Journal"},{"issue":"6","key":"779_CR202","doi-asserted-by":"publisher","first-page":"G1168","DOI":"10.1152\/ajpgi.00219.2004","volume":"287","author":"E Gaudier","year":"2004","unstructured":"Gaudier E et al (2004) Butyrate specifically modulates MUC gene expression in intestinal epithelial goblet cells deprived of glucose. Amer J Physiol-Gastrointest Liver Physiol 287(6):G1168\u2013G1174","journal-title":"Amer J Physiol-Gastrointest Liver Physiol"},{"issue":"12","key":"779_CR203","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1042\/CBI20090481","volume":"34","author":"Z Bai","year":"2010","unstructured":"Bai Z et al (2010) Sodium butyrate induces differentiation of gastric cancer cells to intestinal cells via the PTEN\/phosphoinositide 3-kinase pathway. Cell Biol Int 34(12):1141\u20131145","journal-title":"Cell Biol Int"},{"key":"779_CR204","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7007-11-61","volume":"11","author":"L Wrzosek","year":"2013","unstructured":"Wrzosek L et al (2013) Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol 11:1\u201313","journal-title":"BMC Biol"},{"issue":"10","key":"779_CR205","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1136\/gut.52.10.1442","volume":"52","author":"LE Willemsen","year":"2003","unstructured":"Willemsen LE et al (2003) Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E1 and E2 production by intestinal myofibroblasts. Gut 52(10):1442\u20131447","journal-title":"Gut"},{"issue":"4","key":"779_CR206","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1095-6433(00)00183-5","volume":"125","author":"A Shimotoyodome","year":"2000","unstructured":"Shimotoyodome A et al (2000) Short chain fatty acids but not lactate or succinate stimulate mucus release in the rat colon. Comp Biochem Physiol A: Mol Integr Physiol 125(4):525\u2013531","journal-title":"Comp Biochem Physiol A: Mol Integr Physiol"},{"issue":"3","key":"779_CR207","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1365-2036.1995.tb00386.x","volume":"9","author":"P Vernia","year":"1995","unstructured":"Vernia P et al (1995) Short-chain fatty acid topical treatment in distal ulcerative colitis. Aliment Pharmacol Ther 9(3):309\u2013313","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"779_CR208","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1042\/CS20210778","volume":"136","author":"L Liang","year":"2022","unstructured":"Liang L et al (2022) Gut microbiota-derived butyrate regulates gut mucus barrier repair by activating the macrophage\/WNT\/ERK signaling pathway. Clin Sci 136(4):291\u2013307","journal-title":"Clin Sci"},{"key":"779_CR209","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.3389\/fimmu.2019.02051","volume":"10","author":"G Lewis","year":"2019","unstructured":"Lewis G et al (2019) Dietary fiber-induced microbial short chain fatty acids suppress ILC2-dependent airway inflammation. Front Immunol 10:2051","journal-title":"Front Immunol"},{"issue":"263","key":"779_CR210","doi-asserted-by":"publisher","first-page":"263ra158","DOI":"10.1126\/scitranslmed.3009759","volume":"6","author":"V Braniste","year":"2014","unstructured":"Braniste V et al (2014) The gut microbiota influences blood-brain barrier permeability in mice. Sci Trans Med 6(263):263ra158-263ra158","journal-title":"Sci Trans Med"},{"key":"779_CR211","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bbi.2016.02.020","volume":"56","author":"EE Fr\u00f6hlich","year":"2016","unstructured":"Fr\u00f6hlich EE et al (2016) Cognitive impairment by antibiotic-induced gut dysbiosis: analysis of gut microbiota-brain communication. Brain Behav Immun 56:140\u2013155","journal-title":"Brain Behav Immun"},{"key":"779_CR212","doi-asserted-by":"publisher","first-page":"101483","DOI":"10.1016\/j.arr.2021.101483","volume":"72","author":"M Zhao","year":"2021","unstructured":"Zhao M et al (2021) Interactions between glial cells and the blood-brain barrier and their role in Alzheimer\u2019s disease. Ageing Res Rev 72:101483","journal-title":"Ageing Res Rev"},{"issue":"4","key":"779_CR213","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3390\/cells12040657","volume":"12","author":"E Fock","year":"2023","unstructured":"Fock E, Parnova R (2023) Mechanisms of blood-brain barrier protection by microbiota-derived short-chain fatty acids. Cells 12(4):657","journal-title":"Cells"},{"issue":"2","key":"779_CR214","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/MCO.0000000000000025","volume":"17","author":"E Puertollano","year":"2014","unstructured":"Puertollano E, Kolida S, Yaqoob P (2014) Biological significance of short-chain fatty acid metabolism by the intestinal microbiome. Curr Opin Clin Nutr Metab Care 17(2):139\u2013144","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"9","key":"779_CR215","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/gut.19.9.819","volume":"19","author":"NI McNeil","year":"1978","unstructured":"McNeil NI, Cummings JH, James WP (1978) Short chain fatty acid absorption by the human large intestine. Gut 19(9):819\u2013822","journal-title":"Gut"},{"issue":"11","key":"779_CR216","doi-asserted-by":"publisher","first-page":"9869","DOI":"10.1074\/jbc.M210695200","volume":"278","author":"A Wise","year":"2003","unstructured":"Wise A et al (2003) Molecular identification of high and low affinity receptors for nicotinic acid. J Biol Chem 278(11):9869\u20139874","journal-title":"J Biol Chem"},{"issue":"7","key":"779_CR217","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1158\/0008-5472.CAN-08-4466","volume":"69","author":"M Thangaraju","year":"2009","unstructured":"Thangaraju M et al (2009) GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res 69(7):2826\u20132832","journal-title":"Cancer Res"},{"issue":"4","key":"779_CR218","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1093\/advances\/nmz004","volume":"10","author":"C Alexander","year":"2019","unstructured":"Alexander C et al (2019) Perspective: Physiologic Importance of Short-Chain Fatty Acids from Nondigestible Carbohydrate Fermentation. Adv Nutr 10(4):576\u2013589","journal-title":"Adv Nutr"},{"issue":"10","key":"779_CR219","doi-asserted-by":"publisher","first-page":"1800268","DOI":"10.1002\/bies.201800268","volume":"41","author":"KC Bauer","year":"2019","unstructured":"Bauer KC, Rees T, Finlay BB (2019) The gut microbiota\u2013brain axis expands neurologic function: A nervous rapport. BioEssays 41(10):1800268","journal-title":"BioEssays"},{"key":"779_CR220","doi-asserted-by":"crossref","unstructured":"Knox EG, Aburto MR, Tessier C, Nagpal J, Clarke G, O\u2019Driscoll CM, Cryan JF (2022) Microbial-derived metabolites induce actin cytoskeletal rearrangement and protect blood-brain barrier function. iScience 25(12)","DOI":"10.1016\/j.isci.2022.105648"},{"issue":"1","key":"779_CR221","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/jcbfm.2010.195","volume":"31","author":"Z Wang","year":"2011","unstructured":"Wang Z et al (2011) Valproic acid attenuates blood\u2013brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition. J Cereb Blood Flow Metab 31(1):52\u201357","journal-title":"J Cereb Blood Flow Metab"},{"key":"779_CR222","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bbi.2020.11.032","volume":"92","author":"N Sun","year":"2021","unstructured":"Sun N et al (2021) Antibiotic-induced microbiome depletion in adult mice disrupts blood-brain barrier and facilitates brain infiltration of monocytes after bone-marrow transplantation. Brain Behav Immun 92:102\u2013114","journal-title":"Brain Behav Immun"},{"issue":"1","key":"779_CR223","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1080\/19490976.2017.1371893","volume":"9","author":"J Yan","year":"2018","unstructured":"Yan J et al (2018) Mechanisms of gut microbiota-mediated bone remodeling. Gut Microbes 9(1):84\u201392","journal-title":"Gut Microbes"},{"issue":"6","key":"779_CR224","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.clnu.2009.05.011","volume":"28","author":"JG Bloemen","year":"2009","unstructured":"Bloemen JG et al (2009) Short chain fatty acids exchange across the gut and liver in humans measured at surgery. Clin Nutr 28(6):657\u2013661","journal-title":"Clin Nutr"},{"issue":"9","key":"779_CR225","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1007\/s11064-020-03074-3","volume":"45","author":"C-M Qiao","year":"2020","unstructured":"Qiao C-M et al (2020) Sodium Butyrate Exacerbates Parkinson\u2019s Disease by Aggravating Neuroinflammation and Colonic Inflammation in MPTP-Induced Mice Model. Neurochem Res 45(9):2128\u20132142","journal-title":"Neurochem Res"},{"issue":"9","key":"779_CR226","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.3390\/nu14091882","volume":"14","author":"C-F Tang","year":"2022","unstructured":"Tang C-F et al (2022) Short-chain fatty acids ameliorate depressive-like behaviors of high fructose-fed mice by rescuing hippocampal neurogenesis decline and blood\u2013brain barrier damage. Nutrients 14(9):1882","journal-title":"Nutrients"},{"key":"779_CR227","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-018-0439-y","volume":"6","author":"L Hoyles","year":"2018","unstructured":"Hoyles L et al (2018) Microbiome\u2013host systems interactions: protective effects of propionate upon the blood\u2013brain barrier. Microbiome 6:1\u201313","journal-title":"Microbiome"},{"issue":"18","key":"779_CR228","doi-asserted-by":"publisher","first-page":"9916","DOI":"10.3390\/ijms22189916","volume":"22","author":"V Karoor","year":"2021","unstructured":"Karoor V et al (2021) The short-chain fatty acid butyrate attenuates pulmonary vascular remodeling and inflammation in hypoxia-induced pulmonary hypertension. Int J Mol Sci 22(18):9916","journal-title":"Int J Mol Sci"},{"key":"779_CR229","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/bs.pmbts.2020.11.001","volume":"177","author":"G Forloni","year":"2021","unstructured":"Forloni G et al (2021) Inflammation and Parkinson\u2019s disease pathogenesis: mechanisms and therapeutic insight. Prog Mol Biol Transl Sci 177:175\u2013202","journal-title":"Prog Mol Biol Transl Sci"},{"key":"779_CR230","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.3389\/fimmu.2018.02122","volume":"9","author":"X Chen","year":"2018","unstructured":"Chen X et al (2018) Cerebrospinal fluid inflammatory cytokine aberrations in alzheimer\u2019s disease, parkinson\u2019s disease and amyotrophic lateral sclerosis: A systematic review and meta-analysis. Front Immunol 9:2122","journal-title":"Front Immunol"},{"issue":"1","key":"779_CR231","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12974-019-1528-y","volume":"16","author":"C-H Lin","year":"2019","unstructured":"Lin C-H et al (2019) Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson\u2019s disease. J Neuroinflammation 16(1):129","journal-title":"J Neuroinflammation"},{"key":"779_CR232","doi-asserted-by":"publisher","first-page":"937555","DOI":"10.3389\/fimmu.2022.937555","volume":"13","author":"M Zhu","year":"2022","unstructured":"Zhu M et al (2022) Gut microbiota: a novel therapeutic target for Parkinson\u2019s disease. Front Immunol 13:937555","journal-title":"Front Immunol"},{"key":"779_CR233","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.neuroscience.2020.02.030","volume":"432","author":"JF Baizabal-Carvallo","year":"2020","unstructured":"Baizabal-Carvallo JF, Alonso-Juarez M (2020) The link between gut dysbiosis and neuroinflammation in Parkinson\u2019s disease. Neuroscience 432:160\u2013173","journal-title":"Neuroscience"},{"issue":"6","key":"779_CR234","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson TR et al (2016) Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson\u2019s Disease. Cell 167(6):1469-1480.e12","journal-title":"Cell"},{"key":"779_CR235","doi-asserted-by":"publisher","first-page":"429860","DOI":"10.3389\/fimmu.2019.00239","volume":"10","author":"J Campos-Acu\u00f1a","year":"2019","unstructured":"Campos-Acu\u00f1a J, Elgueta D, Pacheco R (2019) T-cell-driven inflammation as a mediator of the gut-brain axis involved in Parkinson\u2019s disease. Front Immunol 10:429860","journal-title":"Front Immunol"},{"issue":"Suppl. 2","key":"779_CR236","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000518147","volume":"77","author":"M Hirayama","year":"2021","unstructured":"Hirayama M, Ohno K (2021) Parkinson\u2019s disease and gut microbiota. Ann Nutr Metab 77(Suppl. 2):28\u201335","journal-title":"Ann Nutr Metab"},{"issue":"s1","key":"779_CR237","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"E Dorsey","year":"2018","unstructured":"Dorsey E et al (2018) The emerging evidence of the Parkinson pandemic. J Parkinsons Dis 8(s1):S3\u2013S8","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"779_CR238","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/ibd\/izy190","volume":"25","author":"P Weimers","year":"2019","unstructured":"Weimers P et al (2019) Inflammatory bowel disease and Parkinson\u2019s disease: a nationwide Swedish cohort study. Inflamm Bowel Dis 25(1):111\u2013123","journal-title":"Inflamm Bowel Dis"},{"key":"779_CR239","doi-asserted-by":"publisher","first-page":"107272","DOI":"10.1016\/j.intimp.2020.107272","volume":"91","author":"J Tang","year":"2021","unstructured":"Tang J et al (2021) Effect of gut microbiota on LPS-induced acute lung injury by regulating the TLR4\/NF-kB signaling pathway. Int Immunopharmacol 91:107272","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"779_CR240","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/s41419-021-03880-9","volume":"12","author":"F Zou","year":"2021","unstructured":"Zou F et al (2021) Effects of short-chain fatty acids in inhibiting HDAC and activating p38 MAPK are critical for promoting B10 cell generation and function. Cell Death Dis 12(6):582","journal-title":"Cell Death Dis"},{"key":"779_CR241","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbi.2018.02.016","volume":"70","author":"Y Qian","year":"2018","unstructured":"Qian Y et al (2018) Alteration of the fecal microbiota in Chinese patients with Parkinson\u2019s disease. Brain Behav Immun 70:194\u2013202","journal-title":"Brain Behav Immun"},{"key":"779_CR242","doi-asserted-by":"publisher","first-page":"636545","DOI":"10.3389\/fnagi.2021.636545","volume":"13","author":"T Shen","year":"2021","unstructured":"Shen T et al (2021) The association between the gut microbiota and Parkinson\u2019s disease, a meta-analysis. Front Aging Neurosci 13:636545","journal-title":"Front Aging Neurosci"},{"key":"779_CR243","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s11427-016-9001-4","volume":"60","author":"W Li","year":"2017","unstructured":"Li W et al (2017) Structural changes of gut microbiota in Parkinson\u2019s disease and its correlation with clinical features. Sci Chin Life Sci 60:1223\u20131233","journal-title":"Sci Chin Life Sci"},{"issue":"5","key":"779_CR244","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.chom.2015.04.011","volume":"17","author":"TR Sampson","year":"2015","unstructured":"Sampson TR, Mazmanian SK (2015) Control of brain development, function, and behavior by the microbiome. Cell Host Microbe 17(5):565\u2013576","journal-title":"Cell Host Microbe"},{"key":"779_CR245","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bbi.2013.12.005","volume":"37","author":"CG De Theije","year":"2014","unstructured":"De Theije CG et al (2014) Altered gut microbiota and activity in a murine model of autism spectrum disorders. Brain Behav Immun 37:197\u2013206","journal-title":"Brain Behav Immun"},{"issue":"1","key":"779_CR246","doi-asserted-by":"publisher","first-page":"16131","DOI":"10.1038\/s41598-020-72903-w","volume":"10","author":"Y Singh","year":"2020","unstructured":"Singh Y et al (2020) DJ-1 (Park7) affects the gut microbiome, metabolites and the development of innate lymphoid cells (ILCs). Sci Rep 10(1):16131","journal-title":"Sci Rep"},{"issue":"8","key":"779_CR247","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/mds.25882","volume":"29","author":"P Derkinderen","year":"2014","unstructured":"Derkinderen P, Shannon KM, Brundin P (2014) Gut feelings about smoking and coffee in Parkinson\u2019s disease. Mov Disord 29(8):976\u2013979","journal-title":"Mov Disord"},{"key":"779_CR248","doi-asserted-by":"crossref","unstructured":"Kalyanaraman B, Cheng G, Hardy M (2024) Gut microbiome, short-chain fatty acids, alphasynuclein, neuroinflammation, and ROS\/RNS: relevance to parkinson's disease and therapeutic implications, vol 71. Redox Biol 103092","DOI":"10.1016\/j.redox.2024.103092"},{"key":"779_CR249","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.neuroscience.2013.04.037","volume":"246","author":"R St Laurent","year":"2013","unstructured":"St Laurent R, O\u2019Brien LM, Ahmad ST (2013) Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson\u2019s disease. Neuroscience 246:382\u2013390","journal-title":"Neuroscience"},{"key":"779_CR250","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.bbr.2015.05.052","volume":"291","author":"S Sharma","year":"2015","unstructured":"Sharma S, Taliyan R, Singh S (2015) Beneficial effects of sodium butyrate in 6-OHDA induced neurotoxicity and behavioral abnormalities: Modulation of histone deacetylase activity. Behav Brain Res 291:306\u2013314","journal-title":"Behav Brain Res"},{"issue":"7","key":"779_CR251","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nn.4030","volume":"18","author":"D Erny","year":"2015","unstructured":"Erny D et al (2015) Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 18(7):965\u2013977","journal-title":"Nat Neurosci"},{"key":"779_CR252","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jnutbio.2019.03.021","volume":"69","author":"S Srivastav","year":"2019","unstructured":"Srivastav S et al (2019) Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity. J Nutr Biochem 69:73\u201386","journal-title":"J Nutr Biochem"},{"issue":"1 Pt 3","key":"779_CR253","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jfma.2018.06.017","volume":"118","author":"CL Lai","year":"2019","unstructured":"Lai CL et al (2019) Valproate is protective against 6-OHDA-induced dopaminergic neurodegeneration in rodent midbrain: A potential role of BDNF up-regulation. J Formos Med Assoc 118(1 Pt 3):420\u2013428","journal-title":"J Formos Med Assoc"},{"key":"779_CR254","doi-asserted-by":"publisher","first-page":"111376","DOI":"10.1016\/j.exger.2021.111376","volume":"150","author":"Y Hou","year":"2021","unstructured":"Hou Y et al (2021) Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson\u2019s disease. Exp Gerontol 150:111376","journal-title":"Exp Gerontol"},{"issue":"11","key":"779_CR255","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.3390\/molecules25112502","volume":"25","author":"F Ostendorf","year":"2020","unstructured":"Ostendorf F et al (2020) Propionic acid and fasudil as treatment against rotenone toxicity in an in vitro model of Parkinson\u2019s disease. Molecules 25(11):2502","journal-title":"Molecules"},{"issue":"12","key":"779_CR256","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/hmg\/ddx114","volume":"26","author":"I Paiva","year":"2017","unstructured":"Paiva I et al (2017) Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage. Hum Mol Genet 26(12):2231\u20132246","journal-title":"Hum Mol Genet"},{"key":"779_CR257","doi-asserted-by":"crossref","unstructured":"Wang C, Yang M, Liu D, Zheng C (2024) Metabolic rescue of \u03b1-synuclein-induced neurodegeneration through propionate supplementation and intestine-neuron signaling in C. elegans. Cell Rep 43(3)","DOI":"10.1016\/j.celrep.2024.113865"},{"issue":"1","key":"779_CR258","doi-asserted-by":"publisher","first-page":"111772","DOI":"10.1016\/j.yexcr.2019.111772","volume":"387","author":"CM Qiao","year":"2020","unstructured":"Qiao CM et al (2020) Sodium butyrate causes \u03b1-synuclein degradation by an Atg5-dependent and PI3K\/Akt\/mTOR-related autophagy pathway. Exp Cell Res 387(1):111772","journal-title":"Exp Cell Res"},{"key":"779_CR259","doi-asserted-by":"publisher","first-page":"147749","DOI":"10.1016\/j.brainres.2021.147749","volume":"1776","author":"Y Zhang","year":"2022","unstructured":"Zhang Y et al (2022) Sodium butyrate attenuates rotenone-induced toxicity by activation of autophagy through epigenetically regulating PGC-1\u03b1 expression in PC12 cells. Brain Res 1776:147749","journal-title":"Brain Res"},{"issue":"4","key":"779_CR260","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s12264-023-01123-9","volume":"40","author":"W-X Duan","year":"2024","unstructured":"Duan W-X et al (2024) Relationship between short-chain fatty acids and Parkinson\u2019s disease: a review from pathology to clinic. Neurosci Bull 40(4):500\u2013516","journal-title":"Neurosci Bull"},{"issue":"9","key":"779_CR261","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1084\/jem.20160368","volume":"213","author":"NL Rey","year":"2016","unstructured":"Rey NL et al (2016) Widespread transneuronal propagation of \u03b1-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson\u2019s disease. J Exp Med 213(9):1759\u20131778","journal-title":"J Exp Med"},{"key":"779_CR262","doi-asserted-by":"crossref","unstructured":"Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, ... Ko HS (2019) Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models parkinson\u2019s disease. Neuron 103(4):627\u2013641","DOI":"10.1016\/j.neuron.2019.05.035"},{"issue":"6109","key":"779_CR263","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk KC et al (2012) Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338(6109):949\u2013953","journal-title":"Science"},{"issue":"14","key":"779_CR264","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1021\/acschemneuro.1c00144","volume":"12","author":"V Kakoty","year":"2021","unstructured":"Kakoty V et al (2021) Neuroprotective Effects of Trehalose and Sodium Butyrate on Preformed Fibrillar Form of \u03b1-Synuclein-Induced Rat Model of Parkinson\u2019s Disease. ACS Chem Neurosci 12(14):2643\u20132660","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"779_CR265","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1038\/ncomms5500","volume":"5","author":"DI Bolnick","year":"2014","unstructured":"Bolnick DI et al (2014) Individual diet has sex-dependent effects on vertebrate gut microbiota. Nat Commun 5(1):4500","journal-title":"Nat Commun"},{"key":"779_CR266","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.yhbeh.2015.04.013","volume":"76","author":"MM McCarthy","year":"2015","unstructured":"McCarthy MM et al (2015) Surprising origins of sex differences in the brain. Horm Behav 76:3\u201310","journal-title":"Horm Behav"},{"issue":"4","key":"779_CR267","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.maturitas.2010.01.001","volume":"65","author":"JM Pavon","year":"2010","unstructured":"Pavon JM, Whitson HE, Okun MS (2010) Parkinson\u2019s disease in women: a call for improved clinical studies and for comparative effectiveness research. Maturitas 65(4):352\u2013358","journal-title":"Maturitas"},{"issue":"6","key":"779_CR268","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/ane.12796","volume":"136","author":"D Georgiev","year":"2017","unstructured":"Georgiev D et al (2017) Gender differences in Parkinson\u2019s disease: A clinical perspective. Acta Neurol Scand 136(6):570\u2013584","journal-title":"Acta Neurol Scand"},{"issue":"9","key":"779_CR269","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1212\/WNL.55.9.1358","volume":"55","author":"M Baldereschi","year":"2000","unstructured":"Baldereschi M et al (2000) Parkinson\u2019s disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology 55(9):1358\u20131363","journal-title":"Neurology"},{"issue":"2","key":"779_CR270","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/00001648-200203000-00010","volume":"13","author":"A Elbaz","year":"2002","unstructured":"Elbaz A et al (2002) Nonfatal cancer preceding Parkinson\u2019s disease: a case-control study. Epidemiology 13(2):157\u2013164","journal-title":"Epidemiology"},{"issue":"8","key":"779_CR271","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/jnnp.2006.103788","volume":"78","author":"CA Haaxma","year":"2007","unstructured":"Haaxma CA et al (2007) Gender differences in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 78(8):819\u2013824","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"779_CR272","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1128\/AEM.72.2.1027-1033.2006","volume":"72","author":"S Mueller","year":"2006","unstructured":"Mueller S et al (2006) Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 72(2):1027\u20131033","journal-title":"Appl Environ Microbiol"},{"issue":"5","key":"779_CR273","first-page":"400","volume":"9","author":"SB Sherman","year":"2018","unstructured":"Sherman SB et al (2018) Prenatal androgen exposure causes hypertension and gut microbiota dysbiosis. Gut Microbes 9(5):400\u2013421","journal-title":"Gut Microbes"},{"issue":"10","key":"779_CR274","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL (2016) Sex differences in immune responses. Nat Rev Immunol 16(10):626\u2013638","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"779_CR275","doi-asserted-by":"publisher","first-page":"e00046","DOI":"10.1128\/mSystems.00046-17","volume":"2","author":"E d\u2019Hennezel","year":"2017","unstructured":"d\u2019Hennezel E et al (2017) Total lipopolysaccharide from the human gut microbiome silences toll-like receptor signaling. Msystems 2(6):e00046-e117","journal-title":"Msystems"},{"key":"779_CR276","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.maturitas.2018.07.008","volume":"116","author":"JA Santos-Marcos","year":"2018","unstructured":"Santos-Marcos JA et al (2018) Influence of gender and menopausal status on gut microbiota. Maturitas 116:43\u201353","journal-title":"Maturitas"},{"key":"779_CR277","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13293-015-0031-0","volume":"6","author":"P Shastri","year":"2015","unstructured":"Shastri P et al (2015) Sex differences in gut fermentation and immune parameters in rats fed an oligofructose-supplemented diet. Biol Sex Differ 6:1\u201312","journal-title":"Biol Sex Differ"},{"key":"779_CR278","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00535-018-1488-5","volume":"54","author":"T Takagi","year":"2019","unstructured":"Takagi T et al (2019) Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects. J Gastroenterol 54:53\u201363","journal-title":"J Gastroenterol"},{"issue":"4","key":"779_CR279","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/msystems00048-19","volume":"4","author":"H Gao","year":"2019","unstructured":"Gao H et al (2019) Antibiotic exposure has sex-dependent effects on the gut microbiota and metabolism of short-chain fatty acids and amino acids in mice. Msystems 4(4):10\u2013128. https:\/\/doi.org\/10.1128\/msystems00048-19","journal-title":"Msystems"},{"key":"779_CR280","doi-asserted-by":"publisher","first-page":"105661","DOI":"10.1016\/j.neuint.2023.105661","volume":"173","author":"X Zhou","year":"2024","unstructured":"Zhou X et al (2024) The intestinal microbiota exerts a sex-specific influence on neuroinflammation in a Parkinson\u2019s disease mouse model. Neurochem Int 173:105661","journal-title":"Neurochem Int"},{"key":"779_CR281","doi-asserted-by":"publisher","first-page":"100815","DOI":"10.1016\/j.yfrne.2019.100815","volume":"56","author":"M Jaggar","year":"2020","unstructured":"Jaggar M et al (2020) You\u2019ve got male: Sex and the microbiota-gut-brain axis across the lifespan. Front Neuroendocrinol 56:100815","journal-title":"Front Neuroendocrinol"},{"issue":"7","key":"779_CR282","doi-asserted-by":"publisher","first-page":"e1800870","DOI":"10.1002\/mnfr.201800870","volume":"63","author":"JA Santos-Marcos","year":"2019","unstructured":"Santos-Marcos JA et al (2019) Sex Differences in the Gut Microbiota as Potential Determinants of Gender Predisposition to Disease. Mol Nutr Food Res 63(7):e1800870","journal-title":"Mol Nutr Food Res"},{"issue":"6","key":"779_CR283","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/nu10060708","volume":"10","author":"S Gerhardt","year":"2018","unstructured":"Gerhardt S, Mohajeri MH (2018) Changes of Colonic Bacterial Composition in Parkinson\u2019s Disease and Other Neurodegenerative Diseases. Nutrients 10(6):194\u2013202","journal-title":"Nutrients"},{"key":"779_CR284","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbi.2018.02.016","volume":"70","author":"Y Qian","year":"2018","unstructured":"Qian Y et al (2018) Alteration of the fecal microbiota in Chinese patients with Parkinson\u2019s disease. Brain Behav Immun 70:194\u2013202","journal-title":"Brain Behav Immun"},{"key":"779_CR285","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbi.2018.02.005","volume":"70","author":"MF Sun","year":"2018","unstructured":"Sun MF et al (2018) Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson\u2019s disease mice: Gut microbiota, glial reaction and TLR4\/TNF-\u03b1 signaling pathway. Brain Behav Immun 70:48\u201360","journal-title":"Brain Behav Immun"},{"issue":"2","key":"779_CR286","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/15321819.2020.1833917","volume":"42","author":"E Alipour Nosrani","year":"2021","unstructured":"Alipour Nosrani E et al (2021) Neuroprotective effects of probiotics bacteria on animal model of Parkinson\u2019s disease induced by 6-hydroxydopamine: A behavioral, biochemical, and histological study. J Immunoassay Immunochem 42(2):106\u2013120","journal-title":"J Immunoassay Immunochem"},{"issue":"3","key":"779_CR287","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.clnu.2018.05.018","volume":"38","author":"OR Tamtaji","year":"2019","unstructured":"Tamtaji OR et al (2019) Clinical and metabolic response to probiotic administration in people with Parkinson\u2019s disease: A randomized, double-blind, placebo-controlled trial. Clin Nutr 38(3):1031\u20131035","journal-title":"Clin Nutr"},{"key":"779_CR288","doi-asserted-by":"crossref","unstructured":"Liu J, Lv X, Ye T, Zhao M, Chen Z, Zhang Y, ... Sun J (2024) Microbiota-microglia crosstalk between blautia producta and neuroinflammation of parkinson's disease: a bench-to-bedside translational approach. Brain Behav Immun","DOI":"10.1016\/j.bbi.2024.01.010"},{"key":"779_CR289","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.bbi.2020.10.014","volume":"91","author":"J Sun","year":"2021","unstructured":"Sun J et al (2021) Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson\u2019s disease via gut microbiota-GLP-1 pathway. Brain Behav Immun 91:703\u2013715","journal-title":"Brain Behav Immun"},{"issue":"12","key":"779_CR290","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1007\/s10072-019-03975-4","volume":"40","author":"GK Emir","year":"2019","unstructured":"Emir GK et al (2019) The association of low levels of nesfatin-1 and glucagon-like peptide-1 with oxidative stress in Parkinson\u2019s disease. Neurol Sci 40(12):2529\u20132535","journal-title":"Neurol Sci"},{"issue":"4","key":"779_CR291","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/jnc.14694","volume":"150","author":"X Fang","year":"2019","unstructured":"Fang X et al (2019) Neuroprotective effects of an engineered commensal bacterium in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine Parkinson disease mouse model via producing glucagon-like peptide-1. J Neurochem 150(4):441\u2013452","journal-title":"J Neurochem"},{"key":"779_CR292","doi-asserted-by":"crossref","unstructured":"Dong Y et al (2024) Neuroprotective Effects of Bifidobacterium animalis subsp. lactis NJ241 in a Mouse Model of Parkinson\u2019s Disease: Implications for Gut Microbiota and PGC-1\u03b1. Molec Neurobiol 1\u201315","DOI":"10.1007\/s12035-024-04038-2"},{"key":"779_CR293","doi-asserted-by":"publisher","first-page":"105691","DOI":"10.1016\/j.neuint.2024.105691","volume":"174","author":"S Valvaikar","year":"2024","unstructured":"Valvaikar S et al (2024) Supplementation of probiotic Bifidobacterium breve Bif11 reverses neurobehavioural deficits, inflammatory changes and oxidative stress in Parkinson\u2019s disease model. Neurochem Int 174:105691","journal-title":"Neurochem Int"},{"key":"779_CR294","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jns.2017.08.3235","volume":"381","author":"J Liu","year":"2017","unstructured":"Liu J et al (2017) Sodium butyrate exerts protective effect against Parkinson\u2019s disease in mice via stimulation of glucagon like peptide-1. J Neurol Sci 381:176\u2013181","journal-title":"J Neurol Sci"},{"issue":"1","key":"779_CR295","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","volume":"99","author":"MD Sweeney","year":"2019","unstructured":"Sweeney MD et al (2019) Blood-Brain Barrier: From Physiology to Disease and Back. Physiol Rev 99(1):21\u201378","journal-title":"Physiol Rev"},{"key":"779_CR296","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.bbi.2020.07.036","volume":"90","author":"J-F Liao","year":"2020","unstructured":"Liao J-F et al (2020) Lactobacillus plantarum PS128 alleviates neurodegenerative progression in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse models of Parkinson\u2019s disease. Brain Behav Immun 90:26\u201346","journal-title":"Brain Behav Immun"},{"issue":"8","key":"779_CR297","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","volume":"14","author":"GR Gibson","year":"2017","unstructured":"Gibson GR et al (2017) Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol 14(8):491\u2013502","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"779_CR298","doi-asserted-by":"publisher","first-page":"7577","DOI":"10.1007\/s13197-015-1921-1","volume":"52","author":"KR Pandey","year":"2015","unstructured":"Pandey KR, Naik SR, Vakil BV (2015) Probiotics, prebiotics and synbiotics-a review. J Food Sci Technol 52:7577\u20137587","journal-title":"J Food Sci Technol"},{"issue":"2","key":"779_CR299","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3390\/nu12020350","volume":"12","author":"M Wici\u0144ski","year":"2020","unstructured":"Wici\u0144ski M et al (2020) The influence of polyphenol compounds on human gastrointestinal tract microbiota. Nutrients 12(2):350","journal-title":"Nutrients"},{"key":"779_CR300","doi-asserted-by":"publisher","unstructured":"de Vrese M, Schrezenmeir J (2008) Probiotics, prebiotics, and synbiotics. In: Stahl U, Donalies UE, Nevoigt E (eds) Food biotechnology. Advances in biochemical engineering\/biotechnology, vol 111. Springer, Heidelberg. https:\/\/doi.org\/10.1007\/10_2008_097","DOI":"10.1007\/10_2008_097"},{"key":"779_CR301","doi-asserted-by":"publisher","first-page":"465766","DOI":"10.3389\/fneur.2019.00663","volume":"10","author":"TM Cantu-Jungles","year":"2019","unstructured":"Cantu-Jungles TM, Rasmussen HE, Hamaker BR (2019) Potential of prebiotic butyrogenic fibers in Parkinson\u2019s disease. Front Neurol 10:465766","journal-title":"Front Neurol"},{"key":"779_CR302","doi-asserted-by":"crossref","unstructured":"Guo T, and Chen L (2022) Gut microbiota and inflammation in Parkinson\u2019s disease: Pathogenetic and therapeutic insights. Europ J Inflamm 20:1721727X221083763","DOI":"10.1177\/1721727X221083763"},{"issue":"2","key":"779_CR303","doi-asserted-by":"publisher","first-page":"2304313","DOI":"10.21037\/apm-20-1365","volume":"10","author":"H Yang","year":"2021","unstructured":"Yang H et al (2021) A narrative review of relationship between gut microbiota and neuropsychiatric disorders: mechanisms and clinical application of probiotics and prebiotics. Ann Palliat Med 10(2):2304313\u20132302313","journal-title":"Ann Palliat Med"},{"issue":"8","key":"779_CR304","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1021\/acs.jafc.0c07327","volume":"69","author":"Y-S Lee","year":"2021","unstructured":"Lee Y-S et al (2021) Prebiotic lactulose ameliorates the cognitive deficit in Alzheimer\u2019s disease mouse model through macroautophagy and chaperone-mediated autophagy pathways. J Agric Food Chem 69(8):2422\u20132437","journal-title":"J Agric Food Chem"},{"key":"779_CR305","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-018-0523-3","volume":"6","author":"R Grimaldi","year":"2018","unstructured":"Grimaldi R et al (2018) A prebiotic intervention study in children with autism spectrum disorders (ASDs). Microbiome 6:1\u201313","journal-title":"Microbiome"},{"key":"779_CR306","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3389\/fnagi.2017.00403","volume":"9","author":"D Chen","year":"2017","unstructured":"Chen D et al (2017) Prebiotic effect of fructooligosaccharides from Morinda officinalis on Alzheimer\u2019s disease in rodent models by targeting the microbiota-gut-brain axis. Front Aging Neurosci 9:403","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"779_CR307","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.gpb.2021.08.009","volume":"20","author":"A Becker","year":"2022","unstructured":"Becker A et al (2022) Effects of resistant starch on symptoms, fecal markers, and gut microbiota in Parkinson\u2019s disease\u2014the RESISTA-PD trial. Genom Proteom Bioinforma 20(2):274\u2013287","journal-title":"Genom Proteom Bioinforma"},{"issue":"11","key":"779_CR308","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.3390\/antiox10111823","volume":"10","author":"S-P Tsao","year":"2021","unstructured":"Tsao S-P et al (2021) Probiotic enhancement of antioxidant capacity and alterations of gut microbiota composition in 6-hydroxydopamin-induced parkinson\u2019s disease rats. Antioxidants 10(11):1823","journal-title":"Antioxidants"},{"key":"779_CR309","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fnagi.2017.00057","volume":"9","author":"P Perez-Pardo","year":"2017","unstructured":"Perez-Pardo P et al (2017) Promising effects of neurorestorative diets on motor, cognitive, and gastrointestinal dysfunction after symptom development in a mouse model of Parkinson\u2019s disease. Front Aging Neurosci 9:57","journal-title":"Front Aging Neurosci"},{"key":"779_CR310","doi-asserted-by":"publisher","first-page":"111067","DOI":"10.1016\/j.foodres.2022.111067","volume":"155","author":"X Liu","year":"2022","unstructured":"Liu X et al (2022) Polymannuronic acid prebiotic plus Lacticaseibacillus rhamnosus GG probiotic as a novel synbiotic promoted their separate neuroprotection against Parkinson\u2019s disease. Food Res Int 155:111067","journal-title":"Food Res Int"},{"key":"779_CR311","doi-asserted-by":"publisher","first-page":"668775","DOI":"10.3389\/fnagi.2021.668775","volume":"13","author":"BA Nurrahma","year":"2021","unstructured":"Nurrahma BA et al (2021) Probiotic supplementation facilitates recovery of 6-OHDA-induced motor deficit via improving mitochondrial function and energy metabolism. Front Aging Neurosci 13:668775","journal-title":"Front Aging Neurosci"},{"issue":"11","key":"779_CR312","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.3390\/antiox10111823","volume":"10","author":"SP Tsao","year":"2021","unstructured":"Tsao SP et al (2021) Probiotic Enhancement of Antioxidant Capacity and Alterations of Gut Microbiota Composition in 6-Hydroxydopamin-Induced Parkinson\u2019s Disease Rats. Antioxidants (Basel) 10(11):1823","journal-title":"Antioxidants (Basel)"},{"issue":"8","key":"779_CR313","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.neuint.2013.10.006","volume":"63","author":"HM Savignac","year":"2013","unstructured":"Savignac HM et al (2013) Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-D-aspartate receptor subunits and D-serine. Neurochem Int 63(8):756\u2013764","journal-title":"Neurochem Int"},{"issue":"6","key":"779_CR314","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.5114\/aoms.2015.56342","volume":"11","author":"S Bathina","year":"2015","unstructured":"Bathina S, Das UN (2015) Brain-derived neurotrophic factor and its clinical implications. Arch Med Sci 11(6):1164\u20131178","journal-title":"Arch Med Sci"},{"key":"779_CR315","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.neuroscience.2013.04.037","volume":"246","author":"RS Laurent","year":"2013","unstructured":"Laurent RS, O\u2019Brien LM, Ahmad S (2013) Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson\u2019s disease. Neuroscience 246:382\u2013390","journal-title":"Neuroscience"},{"issue":"17","key":"779_CR316","doi-asserted-by":"publisher","first-page":"14941","DOI":"10.1074\/jbc.M110.211029","volume":"286","author":"W Zhou","year":"2011","unstructured":"Zhou W et al (2011) Phenylbutyrate up-regulates the DJ-1 protein and protects neurons in cell culture and in animal models of Parkinson disease. J Biol Chem 286(17):14941\u201314951","journal-title":"J Biol Chem"},{"issue":"5","key":"779_CR317","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/00002826-199210000-00004","volume":"15","author":"R Astarloa","year":"1992","unstructured":"Astarloa R et al (1992) Clinical and pharmacokinetic effects of a diet rich in insoluble fiber on Parkinson disease. Clin Neuropharmacol 15(5):375\u2013380","journal-title":"Clin Neuropharmacol"},{"issue":"6","key":"779_CR318","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/mds.870120617","volume":"12","author":"W Ashraf","year":"1997","unstructured":"Ashraf W et al (1997) Constipation in Parkinson\u2019s disease: objective assessment and response to psyllium. Mov Disord 12(6):946\u2013951","journal-title":"Mov Disord"},{"key":"779_CR319","first-page":"102563","volume":"71","author":"A Bruggeman","year":"2024","unstructured":"Bruggeman A et al (2024) Safety and efficacy of faecal microbiota transplantation in patients with mild to moderate Parkinson\u2019s disease (GUT-PARFECT): a double-blind, placebo-controlled, randomised, phase 2 trial. eClinMed 71:102563","journal-title":"eClinMed"},{"issue":"3","key":"779_CR320","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3390\/applmicrobiol3030067","volume":"3","author":"T Vongsavath","year":"2023","unstructured":"Vongsavath T et al (2023) The potential role of fecal microbiota transplantation in Parkinson\u2019s disease: a systematic literature review. Appl Microbiol 3(3):993\u20131002","journal-title":"Appl Microbiol"},{"key":"779_CR321","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/B978-0-323-99971-7.00002-3","volume-title":"The Gut-Brain Axis","author":"A Markidi","year":"2024","unstructured":"Markidi A et al (2024) Gut Microbes in Parkinson\u2019s Disease: Opportunities for Microbial-Based Therapies. The Gut-Brain Axis. Elsevier, pp 217\u2013240"},{"issue":"6","key":"779_CR322","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson TR et al (2016) Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 167(6):1469-1480.e12","journal-title":"Cell"},{"key":"779_CR323","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbi.2018.02.005","volume":"70","author":"M-F Sun","year":"2018","unstructured":"Sun M-F et al (2018) Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson\u2019s disease mice: Gut microbiota, glial reaction and TLR4\/TNF-\u03b1 signaling pathway. Brain Behav Immun 70:48\u201360","journal-title":"Brain Behav Immun"},{"key":"779_CR324","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1007\/s11064-021-03411-0","volume":"46","author":"Z Zhong","year":"2021","unstructured":"Zhong Z et al (2021) Fecal microbiota transplantation exerts a protective role in MPTP-induced Parkinson\u2019s disease via the TLR4\/PI3K\/AKT\/NF-\u03baB pathway stimulated by \u03b1-synuclein. Neurochem Res 46:3050\u20133058","journal-title":"Neurochem Res"},{"issue":"3","key":"779_CR325","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s13311-019-00719-2","volume":"16","author":"Z-L Zhou","year":"2019","unstructured":"Zhou Z-L et al (2019) Neuroprotection of fasting mimicking diet on MPTP-induced Parkinson\u2019s disease mice via gut microbiota and metabolites. Neurotherapeutics 16(3):741\u2013760","journal-title":"Neurotherapeutics"},{"issue":"1","key":"779_CR326","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2020.9445","volume":"23","author":"T Zhang","year":"2022","unstructured":"Zhang T et al (2022) Gut microbiota relieves inflammation in the substantia nigra of chronic Parkinson\u2019s disease by protecting the function of dopamine neurons. Exp Ther Med 23(1):1\u201310","journal-title":"Exp Ther Med"},{"issue":"26","key":"779_CR327","doi-asserted-by":"publisher","first-page":"e16163","DOI":"10.1097\/MD.0000000000016163","volume":"98","author":"H Huang","year":"2019","unstructured":"Huang H et al (2019) Fecal microbiota transplantation to treat Parkinson\u2019s disease with constipation: a case report. Medicine 98(26):e16163","journal-title":"Medicine"},{"key":"779_CR328","doi-asserted-by":"publisher","first-page":"106791","DOI":"10.1016\/j.clineuro.2021.106791","volume":"207","author":"A Segal","year":"2021","unstructured":"Segal A et al (2021) Fecal microbiota transplant as a potential treatment for Parkinson\u2019s disease - A case series. Clin Neurol Neurosurg 207:106791","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"779_CR329","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12934-021-01589-0","volume":"20","author":"X-Y Kuai","year":"2021","unstructured":"Kuai X-Y et al (2021) Evaluation of fecal microbiota transplantation in Parkinson\u2019s disease patients with constipation. Microb Cell Fact 20(1):98","journal-title":"Microb Cell Fact"},{"issue":"35","key":"779_CR330","doi-asserted-by":"publisher","first-page":"e22035","DOI":"10.1097\/MD.0000000000022035","volume":"99","author":"L-J Xue","year":"2020","unstructured":"Xue L-J et al (2020) Fecal microbiota transplantation therapy for Parkinson\u2019s disease: a preliminary study. Medicine 99(35):e22035","journal-title":"Medicine"},{"key":"779_CR331","doi-asserted-by":"publisher","first-page":"1104759","DOI":"10.3389\/fneur.2023.1104759","volume":"14","author":"HL DuPont","year":"2023","unstructured":"DuPont HL et al (2023) Fecal microbiota transplantation in Parkinson\u2019s disease\u2014A randomized repeat-dose, placebo-controlled clinical pilot study. Front Neurol 14:1104759","journal-title":"Front Neurol"},{"issue":"1","key":"779_CR332","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1017\/S0029665120006916","volume":"80","author":"C Martin-Gallausiaux","year":"2021","unstructured":"Martin-Gallausiaux C et al (2021) SCFA: mechanisms and functional importance in the gut. Proceedings of the Nutrition Society 80(1):37\u201349","journal-title":"Proceedings of the Nutrition Society"},{"issue":"6","key":"779_CR333","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1152\/ajplegacy.1973.224.6.1450","volume":"224","author":"WH Oldendorf","year":"1973","unstructured":"Oldendorf WH (1973) Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids. Amer J Physiol-Leg Content 224(6):1450\u20131453","journal-title":"Amer J Physiol-Leg Content"},{"key":"779_CR334","doi-asserted-by":"publisher","first-page":"111817","DOI":"10.1016\/j.biopha.2021.111817","volume":"141","author":"R Ranjbar","year":"2021","unstructured":"Ranjbar R et al (2021) Immunomodulatory roles of microbiota-derived short-chain fatty acids in bacterial infections. Biomed Pharmacother 141:111817","journal-title":"Biomed Pharmacother"},{"key":"779_CR335","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.fsi.2021.12.035","volume":"120","author":"S Li","year":"2022","unstructured":"Li S et al (2022) SCFAs improve disease resistance via modulate gut microbiota, enhance immune response and increase antioxidative capacity in the host. Fish Shellfish Immunol 120:560\u2013568","journal-title":"Fish Shellfish Immunol"},{"issue":"3","key":"779_CR336","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1039\/C6FO01532H","volume":"8","author":"T Chen","year":"2017","unstructured":"Chen T et al (2017) Dietary fibre-based SCFA mixtures promote both protection and repair of intestinal epithelial barrier function in a Caco-2 cell model. Food Funct 8(3):1166\u20131173","journal-title":"Food Funct"},{"issue":"17","key":"779_CR337","doi-asserted-by":"publisher","first-page":"7014","DOI":"10.18632\/aging.204266","volume":"14","author":"C-T Hong","year":"2022","unstructured":"Hong C-T, Chen J-H, Huang T-W (2022) Probiotics treatment for Parkinson disease: a systematic review and meta-analysis of clinical trials. Aging (Albany NY) 14(17):7014","journal-title":"Aging (Albany NY)"},{"key":"779_CR338","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3389\/fneur.2019.00663","volume":"10","author":"TM Cantu-Jungles","year":"2019","unstructured":"Cantu-Jungles TM, Rasmussen HE, Hamaker BR (2019) Potential of prebiotic butyrogenic fibers in Parkinson\u2019s disease. Front Neurol 10:663","journal-title":"Front Neurol"},{"issue":"3","key":"779_CR339","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","volume":"30","author":"F Scheperjans","year":"2015","unstructured":"Scheperjans F et al (2015) Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype. Mov Disord 30(3):350\u2013358","journal-title":"Mov Disord"},{"key":"779_CR340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-016-0392-y","volume":"9","author":"JR Bedarf","year":"2017","unstructured":"Bedarf JR et al (2017) Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-na\u00efve Parkinson\u2019s disease patients. Genome medicine 9:1\u201313","journal-title":"Genome medicine"},{"key":"779_CR341","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ebiom.2019.05.064","volume":"44","author":"VT Aho","year":"2019","unstructured":"Aho VT et al (2019) Gut microbiota in Parkinson\u2019s disease: temporal stability and relations to disease progression. EBioMedicine 44:691\u2013707","journal-title":"EBioMedicine"},{"issue":"3","key":"779_CR342","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/mds.27581","volume":"34","author":"M Barichella","year":"2019","unstructured":"Barichella M et al (2019) Unraveling gut microbiota in Parkinson\u2019s disease and atypical parkinsonism. Mov Disord 34(3):396\u2013405","journal-title":"Mov Disord"},{"key":"779_CR343","doi-asserted-by":"publisher","first-page":"e00797","DOI":"10.1128\/mSystems.00797-20","volume":"5","author":"H Nishiwaki","year":"2020","unstructured":"Nishiwaki H et al (2020) Short-chain fatty acid-producing gut microbiota is decreased in Parkinson\u2019s disease but not in rapid-eye-movement sleep behavior disorder. mSystems 5:e00797-720s","journal-title":"mSystems"},{"key":"779_CR344","doi-asserted-by":"publisher","first-page":"e00561","DOI":"10.1128\/mSystems.00561-20","volume":"5","author":"S Vascellari","year":"2020","unstructured":"Vascellari S et al (2020) Gut microbiota and metabolome alterations associated with Parkinson\u2019s disease. mSystems 5:e00561-20","journal-title":"mSystems"},{"key":"779_CR345","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.parkreldis.2020.10.034","volume":"81","author":"F Zhang","year":"2020","unstructured":"Zhang F et al (2020) Altered gut microbiota in Parkinson\u2019s disease patients\/healthy spouses and its association with clinical features. Parkinsonism Relat Disord 81:84\u201388","journal-title":"Parkinsonism Relat Disord"},{"key":"779_CR346","doi-asserted-by":"crossref","unstructured":"Rosario D, Bidkhori G, Lee S, Bedarf J, Hildebrand F, Le Chatelier E, ... Shoaie S (2021) Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in parkinson\u2019s disease. Cell Rep 34(9)","DOI":"10.1016\/j.celrep.2021.108807"},{"key":"779_CR347","doi-asserted-by":"publisher","first-page":"632482","DOI":"10.3389\/fimmu.2021.632482","volume":"12","author":"Z Li","year":"2021","unstructured":"Li Z et al (2021) Altered actinobacteria and firmicutes phylum associated epitopes in patients with Parkinson\u2019s disease. Front Immunol 12:632482","journal-title":"Front Immunol"},{"key":"779_CR348","doi-asserted-by":"publisher","first-page":"105187","DOI":"10.1016\/j.micpath.2021.105187","volume":"160","author":"Z Yan","year":"2021","unstructured":"Yan Z et al (2021) Alterations of gut microbiota and metabolome with Parkinson\u2019s disease. Microb Pathog 160:105187","journal-title":"Microb Pathog"},{"issue":"1","key":"779_CR349","doi-asserted-by":"publisher","first-page":"6958","DOI":"10.1038\/s41467-022-34667-x","volume":"13","author":"ZD Wallen","year":"2022","unstructured":"Wallen ZD et al (2022) Metagenomics of Parkinson\u2019s disease implicates the gut microbiome in multiple disease mechanisms. Nat Commun 13(1):6958","journal-title":"Nat Commun"},{"issue":"8","key":"779_CR350","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.3233\/JPD-223500","volume":"12","author":"K Zhang","year":"2022","unstructured":"Zhang K et al (2022) Parkinson\u2019s disease and the gut microbiome in rural California. J Parkinsons Dis 12(8):2441\u20132452","journal-title":"J Parkinsons Dis"},{"issue":"6","key":"779_CR351","doi-asserted-by":"publisher","first-page":"452","DOI":"10.30802\/AALAS-CM-18-000039","volume":"68","author":"MM Haney","year":"2018","unstructured":"Haney MM, Ericsson AC, Lever TE (2018) Effects of intraoperative vagal nerve stimulation on the gastrointestinal microbiome in a mouse model of amyotrophic lateral sclerosis. Comp Med 68(6):452\u2013460","journal-title":"Comp Med"},{"issue":"5","key":"779_CR352","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3920\/BM2017.0202","volume":"9","author":"P Perez-Pardo","year":"2018","unstructured":"Perez-Pardo P et al (2018) Gut bacterial composition in a mouse model of Parkinson\u2019s disease. Beneficial microbes 9(5):799\u2013814","journal-title":"Beneficial microbes"},{"issue":"7770","key":"779_CR353","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41586-019-1443-5","volume":"572","author":"E Blacher","year":"2019","unstructured":"Blacher E et al (2019) Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature 572(7770):474\u2013480","journal-title":"Nature"},{"issue":"2","key":"779_CR354","first-page":"dmm041947","volume":"13","author":"C Figueroa-Romero","year":"2020","unstructured":"Figueroa-Romero C et al (2020) Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice. Dis Models Mech 13(2):dmm041947","journal-title":"Dis Models Mech"},{"issue":"7810","key":"779_CR355","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41586-020-2288-7","volume":"582","author":"A Burberry","year":"2020","unstructured":"Burberry A et al (2020) C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature 582(7810):89\u201394","journal-title":"Nature"},{"key":"779_CR356","doi-asserted-by":"publisher","first-page":"105027","DOI":"10.1016\/j.nbd.2020.105027","volume":"144","author":"V Joers","year":"2020","unstructured":"Joers V et al (2020) Microglia, inflammation and gut microbiota responses in a progressive monkey model of Parkinson\u2019s disease: A case series. Neurobiol Dis 144:105027","journal-title":"Neurobiol Dis"},{"issue":"1","key":"779_CR357","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41522-021-00242-3","volume":"7","author":"Y Yan","year":"2021","unstructured":"Yan Y et al (2021) Gut microbiota and metabolites of \u03b1-synuclein transgenic monkey models with early stage of Parkinson\u2019s disease. NPJ Biofilms Microbiomes 7(1):69","journal-title":"NPJ Biofilms Microbiomes"},{"key":"779_CR358","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-021-01107-9","volume":"9","author":"Z Zhao","year":"2021","unstructured":"Zhao Z et al (2021) Fecal microbiota transplantation protects rotenone-induced Parkinson\u2019s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome 9:1\u201327","journal-title":"Microbiome"},{"issue":"1","key":"779_CR359","doi-asserted-by":"publisher","first-page":"e1152","DOI":"10.1002\/ctm2.1152","volume":"13","author":"A Augustin","year":"2023","unstructured":"Augustin A et al (2023) Faecal metabolite deficit, gut inflammation and diet in Parkinson\u2019s disease: Integrative analysis indicates inflammatory response syndrome. Clin Transl Med 13(1):e1152","journal-title":"Clin Transl Med"},{"key":"779_CR360","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.parkreldis.2022.01.005","volume":"95","author":"E De Pablo-Fernandez","year":"2022","unstructured":"De Pablo-Fernandez E et al (2022) The faecal metabolome and mycobiome in Parkinson\u2019s disease. Parkinsonism Relat Disord 95:65\u201369","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"779_CR361","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/WNR.0000000000001585","volume":"32","author":"T Huang","year":"2021","unstructured":"Huang T et al (2021) The gut microbiota metabolite propionate ameliorates intestinal epithelial barrier dysfunction-mediated Parkinson\u2019s disease via the AKT signaling pathway. NeuroRep 32(3):244\u2013251","journal-title":"NeuroRep"},{"key":"779_CR362","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1423-0127-16-63","volume":"16","author":"SS Ahmed","year":"2009","unstructured":"Ahmed SS et al (2009) Metabolic profiling of Parkinson\u2019s disease: evidence of biomarker from gene expression analysis and rapid neural network detection. J Biomed Sci 16:1\u201312","journal-title":"J Biomed Sci"},{"key":"779_CR363","doi-asserted-by":"publisher","first-page":"147118","DOI":"10.1016\/j.brainres.2020.147118","volume":"1748","author":"B Toczylowska","year":"2020","unstructured":"Toczylowska B et al (2020) Changes in the metabolic profiles of the serum and putamen in Parkinson\u2019s disease patients\u2013In vitro and in vivo NMR spectroscopy studies. Brain Res 1748:147118","journal-title":"Brain Res"},{"key":"779_CR364","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jchromb.2018.01.025","volume":"1081","author":"H Zhao","year":"2018","unstructured":"Zhao H et al (2018) Potential biomarkers of Parkinson\u2019s disease revealed by plasma metabolic profiling. J Chromatogr B 1081:101\u2013108","journal-title":"J Chromatogr B"},{"issue":"3","key":"779_CR365","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3233\/JPD-212604","volume":"11","author":"X He","year":"2021","unstructured":"He X et al (2021) Plasma short-chain fatty acids differences in multiple system atrophy from Parkinson\u2019s disease. J Parkinsons Dis 11(3):1167\u20131176","journal-title":"J Parkinsons Dis"},{"issue":"5","key":"779_CR366","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1007\/s12035-022-03157-y","volume":"60","author":"A Qi","year":"2023","unstructured":"Qi A et al (2023) Plasma metabolic analysis reveals the dysregulation of short-chain fatty acid metabolism in parkinson\u2019s disease. Mol Neurobiol 60(5):2619\u20132631","journal-title":"Mol Neurobiol"},{"issue":"1","key":"779_CR367","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12883-021-02544-7","volume":"22","author":"G Wu","year":"2022","unstructured":"Wu G et al (2022) Serum short-chain fatty acids and its correlation with motor and non-motor symptoms in Parkinson\u2019s disease patients. BMC Neurol 22(1):13","journal-title":"BMC Neurol"},{"key":"779_CR368","doi-asserted-by":"crossref","unstructured":"Kim CH, Jung J, Lee YU, Kim KH, Kang S, Kang GH, ... Lee S (2022) Comparison of metabolites and gut microbes between patients with parkinson\u2019s disease and healthy individuals\u2014a pilot clinical observational study (STROBE Compliant). In: Healthcare, vol 10, no. 2. MDPI, p 302","DOI":"10.3390\/healthcare10020302"},{"issue":"11","key":"779_CR369","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.3390\/cells9112394","volume":"9","author":"A Yilmaz","year":"2020","unstructured":"Yilmaz A et al (2020) Metabolic profiling of CSF from people suffering from sporadic and LRRK2 Parkinson\u2019s disease: a pilot study. Cells 9(11):2394","journal-title":"Cells"},{"key":"779_CR370","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s10072-019-04143-4","volume":"41","author":"S Kumari","year":"2020","unstructured":"Kumari S et al (2020) Quantitative metabolomics of saliva using proton NMR spectroscopy in patients with Parkinson\u2019s disease and healthy controls. Neurol Sci 41:1201\u20131210","journal-title":"Neurol Sci"}],"container-title":["Neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-024-00779-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10048-024-00779-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-024-00779-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T03:05:26Z","timestamp":1730862326000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10048-024-00779-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":370,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["779"],"URL":"https:\/\/doi.org\/10.1007\/s10048-024-00779-3","relation":{},"ISSN":["1364-6753"],"issn-type":[{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,13]]},"assertion":[{"value":"21 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This declaration is \u201cnot applicable\u201d with headings.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Statements"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}